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ABSTRACT
Investigation of the cascade of events that leads to brain formation during
embryogenesis allows an understanding of the processes involved that may well be
applicable to future neurodegenerative therapies. Two genes at work during
embryonic neurogenesis in a brain region called the superior colliculus are Sci, a
member of the basic helix-loop-helix factor transcription factor family and Pax7, a
paired box transcription factor containing a homeobox dornain. The superior
coiliculus forms part of the visual system in mammals and in sepmate studies both the

Sci and Pax? genes have been shown to be present in this fegion of the mouse brain
from early neurogenesis onwards continuing into adulthood. This study was
undertaken to ascertain whether both genes were operating within the same cells
suggesting that they may be part of the same cascade of gene regulat()ry events during
development or co-function in cells of the mature superior colliculus. Mice were
analysed at seven different timepoints from embryonic day (E) 12.5, El5.5, El8.5 to
the day of birth, postnatal day (P) 5, at weaning (P21) and in the adult brain. Their
dissected brains were cryosectioncd and processed for (immuno)histochemistry.
Preliminary results were generated with LacZ stainin!T to detect Sci expression and
immunoperoxidase staining to

detect Pax7.

Confocal microscopy of

(immune )fluorescent stained sections confirmed co-expression.

Interestingly, expression of the Sc1 and Paxl transcription factors was found to
overlap in a large subset of Pax? and Sci positive cells in the superficial layers of the
mature superior colliculus and co-localisation in these cells was confirmed. By
contrast, Paxl and Sci did not co-localise in these cells during embryonic
neurogenesis. Compared with a range of neurogenic transcription factors that are
down-regulated after embryonic neurogenesis, the continued expression of Scl and

Paxl in the adult brain suggests a possible change in function from neuronal
differentiation before birth to a possible concomitant maintenance of the cellular
phenotype function in the adult brain. The lack of co-expression in the embry .mic
brain does not support the hypothesis that Paxl and Sci are involved in the same
developmental cascade of gene regulation. However, the finding that Pax? and Sci
co-localise in mature neurons of the superior colliculus does allow for co-function of
these two transcription factors.

2

DECLARATION
I certify that this thesis does not, to the best of my knowledge and belief:

(i)

incorporate without acknowledgment any material previously submitted

for a degree or diploma in any institution of higher education;
contain any material pre1iously published or written by another person

(ii)

except where due reference is made in the text; or

contain any defamatory material.

(iii)

Signature
Date

{

J1/0t;o5

3

ACKNOWLEDGMENTS
Firstly, I would sincerely like to thank my supervisors, Dr. Anke van Eekelen and Dr.
Mel Ziman for their continuing support, patience and guidance tluoughout the year. If

it were not for their exceptional knowledge and expertise this thesis would not have
been able to be completed to such a high standard.

Special thanks must go to Elena Takano, my proxy lab supervisor. Elena has
displayed extraordinary patience from a barrage of questions and has always 0een

ready to help out when needed. Her own work remains as motivation to always strive
for excellence.

Thanks must also go to the rest of the Cancer Biology team at the Telethon Institute
for Child Health Research. It has been a great pleasure to work with such an
outstanding group of people.

Spec~al

thanks to Kelly Becher for all the genotyping

that she has performed for me throughout the year and to Lan Doan for her continual
good humour and support. I wish all in the lab continued success.

Fortunately, I have also been a part of another group of exceptional students and I
would like to thank my ECU buddies for their help, support and down-to-earth advice
over the year. The work they perfonn is first class and as a collective, the group is
one of Edith Cowan Uni·versity's greatest assets. It has been an honour to be a part of
this team and I wish them all great success in tb.e future.

To my family and friends who have barely seen me this year, thankyou for your
support, encouragement and patience as I put the rest of my life on hold. Special
thanks to my husband Mark and children, Luke and Jake who have had to put up with
the greatest inconveniences and are still so proud of my efforts at the end of the day. I
love yout And of course, to my Mum and Dad who were the inspiration behind the
journey. God Bless.

4

TABLE OF CONTENTS

Page

1.

2.

Abstract

3

Declaration

4

Acknowledgements

5

Table of Contents

6

INTRODUCTION ................................................. ,. ......................................... ?
1.1.

BACKGROUND TO THE STUDY ........................................................................... 8

1.2.

SIGNIFICANCE OF THE STUDY ............................................................................ 9

1.3.

HYPOTHES!S ............................................................................................................. 9

1.4.

AIM .............................................................................................................................. 9

LITE/1AJfURE REVIEW ............................................... ,............................... JO
2.1

THESCLGENE ........................................................................................................ II

2.1.1.

Sci is an oncogene in T-cell Acute Lymphoblastic Leukaemia (f-ALL)

2.1.2.

Sci encodes a bHLH transcription factor

2.1.3,

Characterisation of enhancer sequences in the Scl gene

2.1.4.

The function of Sci in haematopoiesis

2.1.5.

The function of Sci in the CNS 13

2.2.

The Crc/loxP System

2.2.2.

Reporter gnes

12

12

14
15

THEPAX7 GENE ...................................................................................................... IS

2.3.1.

Pax? is a transcription factor with a paired domain

2.3.2.

Neural enhancers of Paxl

2.3.3.

The function of Paxl in the musculo-skeletal system 20

2.3.4.

The function of Pax? in the CNS

2.4.

3.

II

TRANSGENIC MOUSE MODELS ......................................................................... 14

2.2.1.

2.3.

II

18

20

21

TRANSCRIPTION FACTORS AND BRAIN DEVELOPMENT .......................... 22

2.4.1.

The midbrain/hindbrain boundary development

22

2.4.2.

The midbrain/forebrain boundary development

24

2.4.3.

Development of the superior colliculus

2.4.4.

Summary 26

24

MATERIALS AND METHODS .................................................................... 28
3.1.

ETHICALCONSIDERATIONS .............................................................................. 29

3.2.

EXPERIMENTAL PROCEDURES ......................................................................... 29

5

4.

3.2.1.

Mouse Models

29

3.2.2.

Timed pregnancies

30

3.2.3.

Harvesting embryos 30

3.2.4.

Tamoxifen Injections

3.2.5.

Cross fostering of tamoxifen treated embryos

3.2.6.

Anaesthetic

31

3.2.7.

DNA Isolation

32

3.2.8.

Genotyping of genetically manipulated mice using Real-time PCR

3.2.9.

Transcardial Pelfusion for the fixation of brain tissue 35

3.2.10.

Ice Hypothennia and transcardial pelfusion of mouse pups

3.2.11.

Frozen Blocks

3.2.12.

LacZ histochemistry 36

3.2.13.

Immunohistochemistry of mouse brain tissue for antibodies raised in mice 36

3.2.14.

Immunofluorescence for Pax7 37

3.2.15.

Microscopic Analysis

3.2.16.

Research Design

30

35

38

38

RESULTS ...................................................................................................... 41
4. I.

LACZ STAINING

42

4.2.

PAX? STAINING

42

4.3.

FLUORESCENT AND CONFOCAL MICROSCOPY

4.4.

NEURONAL MARKER~

4.5.

MAPPING OF EXPRESSION PATTERNS IN THE BRAIN

4.6.

El2.5 TIMEPOINT

48

4.7.

El5.5 TIMEPOINT

48

4.8.

El8.5 TIMEPOINT

50

4.9.

PO TIMEPOINT

51

4.10. PS T!MEPO!NT

54

43

43

56

DISCUSSION ......................... ,...................................................................... 59
5.1.

NEW FINDINGS IN THIS STUDY

5.2.

CHANGE OF FUNCTION OVER TIME FOR PAX7 AND SCL

5.3.

DYNAMIC EMBRYONIC EXPRESSION PATTERNS OF PAX7 AND SCL 62

5.4.

GENERATION OF AN EXPRESSION MAP FOR PAX7

5.5.

APPLICATION OF GENETICALLY MANIPULATED REPORTER MICE FOR

5.6.

6.

32

35

4.11. P21 ANDADULTTIMEPOINT

5.

31

SCL EXPRESSION

64

FUTURE RESEARCH

65

60
60

63

REFERENCES .............................................................................................. 67
6

1. INTRODUCTION
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1.1 BACKGROUND TO THE STUDY
The Stem Cell Leukaemia (Sci) gene encodes a basic

helixMloop~hdix

transcription

factor that was originally identified through a translocation of the gene to the T-cell
receptor locus in acute lymphoblastic leukaemia The gene is essential for the early
development of the haematopoietic and vasculogenic system (B('gley and

Gre~n.

1999). Studies indicate that Sci functions as a cell fate determinant in the
haematopoietic system by regulating the proliferation of multi potent haematopoietic

stem cells (Green ct al., 1991; Elefanty et al., 1997), directing the differentiation of
erythroid cells, megakaryocytes and mast cells (Green et al., 1991) and developing

the yolk sac vessels (Robb et al., 1995). Sci expression has also been found in the
central nervous system and the expression pattern of Sci in the b1·ain has been mapped
using an Sci LacZ knockin reporter mouse. The expression mapping shows a high
degree of expression in the dorsal superficial layers of the superior colliculus, the
pretectal area, the tegmental regions and moderate to low density expression
throughout the midbrain, hindbrain and caudal thalamus (van Eekelen et al., 2003). A
recent Sci gene deletion study has indicated that. Sci is required for normal
mid/hindbrain development, suggesting a cell fa1.e determinant role for Sci in
neurogenesis (data to be submitted for publication by van Eekelen et al.).

The Pax? transcription factor is encoded by a member of the paired box gene family
first identified in Drosophila (Bopp et al., 1986). The expression pattern of the Pax7
gene suggests a functional role in development of neural crest, skeletal muscle and
the central nervous system (Mansouri et a!., 1996). Pax? appears to be a significant
factor during brain development, functioning in regionalisation and polarity of the
superior colliculus. Pax? has also been implicated with refining the optic nerve
innervation to the dorsal layers in the superior colliculus dming early postnatal
development (Thomas et al., 2004). The adult Pax7 expression pattern is similar to
that of the late embryo with prominent expression found in the dorsal superficial
layers of the superior colliculus (Stoykova and Gruss, 1994).

The Sci and Pax7 genes display a high level of expression during embryonic
neurogenesis particularly in the mesencephalon (midbrain) during the formation of
the superior colliculus. Both factors continue to be expressed in the dorsal layers of
the superior colliculus in postnatal and adult brain (Stoykova and Gruss, 1994;
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Nomura et al., 1998; Matsunaga, 2001; van Eekelen et al., 2003; Thomas et al.,
2004). This spacio-temporal overlap in expression suggests that Sci and Pax7 may be
invoived in related functions during brain development and in the adult brain.
Expression of Sci and Pax7 throughout embryonic neurogenesis, implies a function in
detennining cell fate andJor differentiation, particularly in the superior colliculus
(Stoykova and Gruss, 1994; van Eekelen et al., 2003). In addition, with the
expression of both factors in regional organisational centres of the developing brain, a
regionalisation function is suggested (Kawakami et al., 1997; Matsunaga, 2001; van
Eekelen et al., 2003) and continued expression in post-mitotic cells after birth also
implies a role in the maintenance of the cellular phenotype of Sci and Pax7
expressing neurons (Stoykova and Gruss, 1994; van Eekelen eta!., 2003).

1.2 SIGNIFICANCE OF THE STUDY
This study will help detennine more accurately the roles of Scl and Pax7 in neuronal
function and contribute to the understanding of factors involved in embryonic and
adult neurogenesis. This is essential for future development of possible therapies for
neurodegenerative diseases based on the endogenous generation of new neurons in
the adult brain, rather than by transplantation methods or gene therapy.

1.3 HYPOTHESIS

Pax7 and Scl co-localise within cells of the mesencephalon from embryonic
neurogenesis to adulthood indicating a co-ordinated neurogenic function of both
transcription factors in developing and mature neurons.

1.4 AIM
The aim of this study is to investigate the co-expression of the Sci and Pax7 genes as
a basis for a common functional role of the two genes in embryonic, postnatal and
adult brain. To do this a detailed morphological analysis of Pax7 and Scl colocalisation in the brain at different stages of embryonic neurogenesis as well as after
birth, at weaning and in the adult brain will be performed. This detailed analysis
includes the generation of an accurate but so far not reported map on the expression
pattern of Pax7 during embryonic neurogenesis and postnatal development.
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2. LITERATURE REVIEW

!0

2.1 THE Sci GENE

2.1.1. Sci is an oncogene in T-ce/1 Acute Lymphoblastic Leukaemia
(F-ALL)

The Sci gene, also referred to as Tcl-5 and Tal-l, was originally identified through a
translocation from chromosome 1 into the

T~cell

receptor locus on chromosome 14.

At the new locus, aberrant production of the transcription factor caused the gene to
become oncogenic leading to T-ALL. Further, deit:t\ons at chromosome 1 have put

the Sci

g~ne

under the control of the ubiquitous Sit promoter also resulting in T-ALL

oncogenic function. The mechanism involved in transforming the cells into a
leukemic state is unknown but Sci is thought to increase proliferation and decrease

cell death (Begley and Green, 1999).
2.1.2

Sci encodes a bHLH transcriptwn factor

Basic .helix-Iovp-helix (hHLH) transcription factors play a major role during
embryogenesis in determining neuronal subtype specification and differentiation
(Guillemot et al., 1993). The bHLH structure contains two important binding domains
with the basic domain facilitating DNA binding while the helix-loop-helix domain
l:dnds other proteins to form heterodimers. Scl is a class B HLH protein known to
bind with class A proteins such as E2A, that acts as a transcriptional activator, to
form a heterodimer that binds DNA at the E-box of downstream gene enhancers,
regulating developmental pathways (Hsu et al., 1991). Sci binds to CAGGTG Eboxes with a higher binding affinity if the E-box is followed by a GATA motif or
with a lower binding affinity if an upstream CAGATG E-box is nearby (CohenKaminsky et al., 1998). The HLH domain can bind with other proteins to form a
larger protein complex. The individual proteins involved in complexes may have no
singular effect on downstream target genes but may all be necessary compm:ents in
order to activate the synergistic complex in an all or nothing manner (Lecuyer and
Hoang, 2004) . The specific protein interactions allow for a precise spacio-temporal
activation of the target gene. Specific complexes will differentially activate each
target gene. A protein change within a multifactorial complex may make for a more
efficient activator to certain downstream genes (Lecuyer and Hoang, 2004). There are
a number of Sci isoforms that may well vary the activational function of a complex
and create diversity between cell types, regions and stages of differentiation. (Begley

and Green, 1999; Calkhoven eta!., 2002).
II

2.1. 3. Characterisation ofenhancer sequences in the Sci gene
The Sci gene is expressed in the haematopoietic system, endothelial cells and the
brain and specific enhancers within the Sci locus have been identified to direct Sci
expression specifically to these functionally different cell types. A 3' Sci enhancer
has been described that targets the haemangioblast, a precursor for both
haematopoietic stem cells and endothelial cells (Gottgens et al., 2002) and a 5'
endothelial enhancer has also been demonstrated. Of concern to this project is the 5'
Sci neural enhancer (940bp) used in the construct of a transgenic mouse model that

directs transgene expression under this regulatory gene sequence stretching from
-0.9kb to Exon 3 (0.9E3). This enhancer is important for Sci expression within the
midbrain, hindbrain and spinal cord. Exon Ia forms part of the promoter and is
essential for directing expression to the midbrain (Sinclair et al., 1999).

2. 1. 4. The function ofSci in haematopoiesis
Early research an Sci has shown that the Sci gene is essential for the early
development cf the haematopoietic and vasculogenic systems (Begley and Green,
1999). Functional studies of the haematopoietic system have found Sci expressed in
primitive haematopoictic stem cells, progenitor cells and differentiated erythrocytes,
megakaryocytes and mast cells (Hall et al., 2003). Sci regulates multi-potent
haematopoietic cell proliferation, facilitates erythroid differentiation and inhibits
myeloid differentiation (Kallianpur, 1994; Begley and Green, 1999). A conserved
upstream open reading frame acts as a

trm~s!ational

control mechanism regulating

differing Sci isoforms. The isoforms vary in the translation of theN terminus while
all retain the bHLH domain. Specific Sci isoforms determine lineage commitment
with the truncated Sci isoform promoting the erythroid lineage while the full length
Sci protein follows the megakaryocyte lineage (Calkhoven et al., 2002). Evidence
that Sci is a critical factor within haematopoiesis is displayed in the knockout model
by the failure of embryos to survive beyond E9.5 with death occurring from hypoxia
following on from absolute anaemia and yolk sac failure (Robb et al., 1995) at the
stage when foetal circulation is meant to conunence. While embryonic blood vessels
develop typically in the knockout model, vessels within the yolk sac display no
patterning and fail to develop without Sci (E:efanty et al., 1997). To functionally
assess Sci in the adult haematopoietic system, conditional Sci-null mice based on the
12

Mx-Cre/ioxP system have been developed that knock out the Sci gene upon interferon
administration at a chosen timepoint. These studies have shown that Sci has a
function in adult haematopoiesis by maintaining megakaryocyte production and
erythropoiesis. Macrophages, granulocytes and myeloid progenitors are unaffected by
the Sci deficiency even though Scl expression is found within the myeloid progenitor
(Hallet a!., 2003).

2.1.5. The function ofSci in the CNS
Sci expression in the central nervous system has been mapped using a Scl LacZ
knockin reporter mouse (van Eekelen et al., 2003). Sci is expressed in regions of the
foetal brain known to differentiate into the Scl expression domains of the adult brain.
Expression is found in the diencephalon (caudal thalamus of the forebrain), the
mesencephalon (midbrain) including the superior colliculus and substantia nigra and
in metencephalon (hindbrain) (van Eekelen et al., 2003). Sci does not express in glial
cells but it does in post-mitotic neurons. In general, Scl expressing cells are found
evenly scattered over different brain regions suggesting that only a percentage of cdls
express Sci (van Eekelen et al., 2003). Embryonic Sci expression surrounds the
aqueduct in the intermediate and marginal zone of the neuroepithelium and the fourth
ventricle in the ventricular zone suggesting an involvement in the differentiation and
possible neuronal subtype specification of migrating neurons from neural stem cells
during development (van Eekelen et al., 2003).

The most prevalent Sci staining in the adult brain is seen in the superior colliculus
with a decreasing expression gradient observed over the seven layers from dorsal to
ventral. There is a high density of LacZ staining in the dorsal zonal and superficial
grey layers of the superior colliculus, a moderate density in the optic layer and a low
density jn the intermediate and deep layers. Low density Sci expression is seen in the
cortex of the inferior colliculus (van Eekelen et al., 2003). Scl expression in the
superior colliculus particularly implies a potential role in the oculomotor, pupillary
and retinotectal visual pathway. Functional studies on the role of Sci in the central
nervous system are currentlY being undertaken using conditional gene knockout
mouse models that knockout the gene within the brain only. Preliminary results show
that the spatial Scl knockout in the brain results in a runted animal with 25% of
animals dying at birth and a further 35% at weaning age and are growth retarded. The
13

remaining animals display hyperactive behaviour. Furthermore, a subset of neurons
that express Sci in the normal brain are absent in the mid and hindbrain of the
condition~! knockout and suggest a crucial role for Sci during brain development.

(Personal communication from JAM van Eekelen at the Telethon Institute for Child
Health Research).

2.2 TRANSGENIC MOUSE MODELS

In order to make functional hypotheses for specific genes, researchers have been
manipulating the pluripotent embryonic stem cells of mice to make gene knockout
mouse models by homologous recombination. A phenotypic analysis of loss of
function may be made by replacing the gene sequence with an alternative construct,
deleting the gene from the genome or knocking in a different gene, to give an
indication of function (Garcia and Mills, 2002). The complete removal of some genes
from the genome results in a lack of offspring because the gene concerned is
necessary for the development and survival of the anima!. Such is the case for the Sci
gene, which is imperative to the development of the haematopoietic system rendering
an ombryo unviable beyond E9.5 (Robb et al., 1995). By using the full Sci knockout

model it is impossible to study Sci function in the brain. Conditional gene models
have been designed to circumvent the problems of lethality during embryogenesis
allowing genes to be deleted in both a spatial and temporal manner (Garcia and Mills,
2002).

2. 2.1

The CrelloxP System

Cre recombinase (Cre) is an enzyme produced in the bacteriophage PI that
recombines DNA at specific recognition sites called loxP sites. ThP. loxP sites have
two 13bp inverted repeat regions that bind Cre and a central 8bp spacer where
cleavage and recombination occur. When bound by Cre, L"le DNA between two loxP
sites is cleaved (Sternberg and Hamilton, 1981). Genetically manipulated mice are
inter-crossed to produce offspring that carry two loxP sites on either side of a
pertinent area of the gene in quedtion (flexed) and also carry the Cre sequence within
its genome. When Cre is expressed it will recombine the loxP sites by cleaving the
gene sequence in between (Fig. 2-1.) (Garcia and Mills, 2002).
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LoxP site

LoxP site

~------~:::~;> bHLH ~----------~

+
Recombination

@

Cleaved Scl sequence

Figure 2-1. The conditional Sci knockout mouse. Cre recombinase, produced under the neural-specific Nestin
promoter, will bind two LoxP s ites, cleave and circularise the DNA in between and recombine the original strand.

The previously mentioned conditional Sci knockout model has been generated such
that, Cre expression is regulated by the promoter and neural tissue-specific enhancer
of the proneural gene, Nestin (Tronche et al., 1999). LoxP sites have been inserted
into Sci flanking the region encoding the bHLH domain (Fig. 2. 1). Cleaving of the
gene is spatially restricted to the brain because Cre is only expressed in the neural
progenitor cells.

2. 2. 2. Reporter genes

In most cases where knockout models have been generated, the gene of interest has
been replaced by a knockin gene being a reporter gene placed under the control of the
regulatory sequences of the gene of interest. This has been done for Scl and has
provided an excellent Scl-LacZ knockin reporter mouse to study the expression
pattern of Sci in the brain. The LacZ reporter gene has been knocked-in to the Sci
locus (Fig. 2.2) in the region encoding the translational sequence of the Scl gene and
is expressed under the Scl endogenous promoter in all Scl expressing cells.
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LacZ Kl

1a 1b 2
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ex on

Figure 2.2: The LacZ reporter gene is knocked into the Sc/ locus at the bHLH site and expressed under the
SCL promoter.

The LacZ reporter mouse is extremely useful for gene expression studies within the
brain because the Sci monoclonal antibodies that can be used for Western blotting are
ineffective in the immunohistochemical studies on brain sections. Once the f)galactosidase enzyme assay has been completed on tissue sections, a blue reaction is
visualised (Hatton and Lin, 1992) where Sci is normally expressed. To avoid creation
of a knockout mouse, heterozygous mice are used, which express the LacZ reporter
gene from one allele while the normal expression of Scl still occurs from the other.

Unfortunately, the LacZ signal is not strong enough for immunofluorescent
histochemistry using an antibody against the X-gal protein. As an alternative, a
mouse model containing the enhanced Yellow fluorescent protein (eYfp) reporter has
been developed. e Yfp is knocked-in to the Rosa26 locus, which is a housekeeping
gene ubiquitously expressed and resulting in a high level of fluorescence (Srinivas et
al., 2001 ). Moreover, a stop sequence flanked by LoxP sites precedes the reporter
gene in this knockin mouse resulting in e Yfp expression only if the stop sequence is
recombined/deleted by Cre (Fig. 2.3); (Srinivas et al., 2001 ).

In the group supervised by Dr. van Eekelen at ICHR, aCre transgenic mouse has
been generated in which Cre is expressed under the control of the 5' Sci neural
enhancer (0.9E3) and . is produced only in Sci expressing neurons. Thus until the
16

expression of Cre no eY fp will be produced in Sci-expressing neurons because of the
presence of a stop sequence at the start of the e Yfp gene. However, upon Cre
expression, the stop sequence is cleaved and eYfp is produced.

--0
--------...

CYTOPLASM

~~

CreERT

NUCLEUS

Figure 2.3 Cre recombinase is expressed under the Sci neural e nhancer and fused to an oestrogen receptor ligandbinding domain. The protein is held within the cytoplasm by the heat shock protein 90. On the administration of
tamoxifen, heat shock protein 90 is released, a conformational change is induced and Cre enters the nucleus where
it c leaves the stop sequence and e Yfp is expressed under the ubiquitous GTRosa promoter.

To add temporal control over deletion of the floxed gene of interest (R26R-EYfp in
this study), the 0.9E3 Cre transgenic mouse was generated as an inducible Cre mouse
with Cre fused to a mutated oestrogen receptor ligand-binding domain constructed to
mimic the nuclear hormone receptor (Brocard et al., 1997). When the hormone binds
to the receptor, the protein is translocated into the nucleus for DNA binding (Fig 2.3).
Without hormonal binding the protein remains in the cytoplasm bound to heat shock
protein 90. The introduced oestrogen receptor ligand-binding domain is mutated such
that Cre can only be activated by tamoxifen (Fig. 2.3). The three mutations within the
17

receptor prevent the binding of endogenous oestrogen (Brocard et al., 1997). Taken
together, eYfp expression in the brain will reflect Sci neural expression upon
tamoxifen administration.

The different models discussed are of relevance to this study as the Sci antibody is
ineffective when immunostaining brain tissue. The Scl-LacZ knockin model has been
designed as a reporter for Sci expression, displaying good morphology and suitable
for light microscopy while the Brain-Cre x GTRosa26-e YJP model has been valuable
for fluorescent and confocal microscopy. These conditional mouse models allow us to
perform several experiments that enhance or further our understanding of the role of

Sci in the CNS.
2.3 THE Pax7 GENE

2.3.1. Paxl is a :ranscriptionfactorwith a paired domain
The Paxl gene encodes a transcription factor that contains a paired DNA binding
domain first identified in the paired protein of Drosophila me lanagaster (Bopp et al.,
1986). The Pax7 gene is one of nine family members 1hat encode a DNA binding
domain from a gene region called the paired box (Pax). The encoded paired domain
forms six a-helices grouped into two helix-turn-helix motifs, is 128 amino acids long,
and in close proximity to the amino terminus of the protein. In addition, Pax?
contains a 61 amino acid paired type homeodomain (Jostes et al., 1990; Stoykova and
Gruss, 1994) as well as a conserved octapeptide sequence (Fig 2.4). Pax proteins, like
other transcription factors are thought to bind enhancer sequences of downstream
genes with their DNA binding domains.

The Pax proteins have been grouped into different classes according to their structural
differences and Pax7 has been, classified as a Class II protein as it contains the paired
box DNA binding domain, the full length homeodomain encoding region and the
conserved octapeptide (Ziman et al., 2001 b). Pax? also contains a transactivation
domain (Fig. 2.4) binding other proteins to induce downstream gene transcription
(Ziman eta!., 200Ia).

18

Paired
domain

Transactivation
domain

Figure 2.4
Pax7 protein schematic showing the subdomains of the paired domain, each
containing a helix-turn-helix motif, an octapeptide, the helix-turn-helix homeodomain and the proteinbinding transactivation domain (Chi and Epstein, 2002).

Another Class II protein homologous to Pax7 is Pax3, with a structure closely
resembling that of Pax7 and thought to offer partial redundancy where the expression
domains overlap (Mansouri et al. , 1996). The diversity in function of Pax7 throughout
development is thought to be explained by the identification of different protein
isoforms. Alternate splicing regions within the intron-exon boundaries of the Pax7
paired box encode different proteins thought to operate in specific spatial and
temporal domains. The alternate splicing within the paired box region may modify
the proteins tertiary structure, thus altering DNA binding and activating different
pathways (Ziman et al., 2000; Ziman et al., 2001 a). Further, six different PAX7
allelic forms have heen identified.
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2.3.2. Neural enhancers ofPax7
The distinct expression patterns of Pax7 within the central nervous system are under
the regulatory control of more than one enhancer. While the promoter region of Pax?
is located -2.lkb upstream ofExonl, an enhancer region is positioned within the first
intron of the gene regulating expression of Pax7 in the brain region, the pons. By
contrast, Pax7 expression at the midbrain/hindbrain boundary and the cerebellar
ventricular zone is regulated by elements -4kb upstream of the gene. An enhancer
situated within the upstream -1 Okb of Pax? regulates the roof plate, cephalic neural
crest and mesencephalic tecta! expression (Lang et a!., 2003). Within the upstream
promoter region of Pax7, seven different E-boxes have been observed. At -2073 there
is a CACCTG sequence, -1861 has a CAGGTG sequence, -1393 has a CATCTG
sequence, -1051 has a CACGTG sequence and -956, -570 and -280 all have the
CAGCTG E-box sequence (Personal communication Rob White, Centre for Human

Genetics). TheE-box sequences located within the promoter region upstream of Pax7
make an opportune site for other transcription factors such as Sci to binrl and induce

Pax7 expression perhaps as part of a neurogenic pathway.

2.3.3. The function of Pax7 in the musculo-skeletal system
The expression pattern of Pax7 suggests that it has a ftmction in cephalic neural crest
cells and the development of skeletal muscle as well as the central nervous system
(Gruss and Walther, 1992). From E9, early dorso-ventral somite patterning is thought
to be regulated by Pax7 and Pax3. Pax? expression is then restricted to the
dennamyotome. Later it is observed in skeletal muscle progenitors (Kawakami et al.,
1997) and in the intercostal muscles (Jostes et al., 1990). A myogenic progenitor cell
termed a satellite cell is found as a quiescent muscle precursor nonnally adjoining
mature muscle fibres. Duriug muscle regeneration, satellite cells proliferate and fuse
to form new muscle fibres. Persistent Pax7 expression maintains the precursors in an
undifferentiated state, remaining expressed when cells are activated but disappearing
on terminal differentiation. Satellite cells are ab::;ent in the Pax? knockout mice and a
runted animal results, deficient in postnatal skeletal muscle growth (Seale et al.,

2000).
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2.3.4. The junction ofPax7 in the CNS

The Pax genes are implicated in a variety of functions based on temporal and spatial
restriction of expression in the brain from early embryogenesis through to early

postnatal development. Pax7 initially expresses in the neural tube at embryonic day 8
along the dorso-ventral axis during neural tube development and before cellular

differentiation (Jostes et al., 1990; Stoykova and Gruss, 1994; Nomura et al., 1998).
Once the neural tube has closed, the neural epithelium becomes a mitoticaii:v active
ventricular zone generating stem cells for the developing central nervous system. At
this time, Pax 7 persists in the dorsal ventricular zone until the ventricular zone

reduces reducing its mitotic activity (E14) (Jostes et al., 1990). Pax genes then
display a role in regional differentiation of the embryonic brain by expressing within
or between regions that correlate to anatomical borders (Stoykova and Gruss, 1994).
Pax? and Pax3 are part of the cascade that delineates the midbrain from the forebrain

(Stoykova and Gruss, 1994) while the homologues Pax2 and Pax5 are expressed at
the midbrain/hindbrain boundary (Stoykova and Gruss, 1994; Bouchard eta!., 2000).
From the delineation of anatomical borders, Pax? is then involved in establishing
regionalisation and polarity of the superior colliculus (optic tectum). This has been
demonstrated by the misexpression of Pax7 in the diencephalon inducing the
formation of an ectopic tectum showing innervation and lamination by retinal axons
(Matsunaga, 2001). During embryogenesis, Pax? expressing cells migrate from the
ventricular zone to the stratum griseum superficiale, a region of the superior
colliculus that later receives retinal ganglion cell input. This implies a later
specification and/or differentiation role for Pax?. Pax? displays an expression
gradient of rostral10w- caudalhigh and dorsalhigh- ventral10w within the tectum throughout
development implying a role in the polarity of the superior colliculus (Thomas et al.,
2004). Co-expression of Pax? with ephrin-A2 during early postnatal development,
suggests a role for Pax? in establishing the retinotectal

m~p

and refining optic nerve

innervation. Pax? achieves this in part by regulating ephrin-A2 expression (Thomas et
al., 2004). In the adult brain, Pax? expression is found along the rostra-caudal axis of
the brain with particularly high expression levels within the dorsal superior colliculus
similar to expression patterns in the embryonic brain (Stoykova and Gruss, 1994).
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The Pax7 knockout mouse survives to term but usually dies prior to weaning while
the heterozygous animal develops and reproduces normally. Phenotypically, the
knockout exhibits severe growth retardation with a shortened maxilla, smaller serous
gland tubules and a pointed snout. Derivatives from areas of overlapping temporal
expression of Pax3/7 in the neural tube appear normal in the Pax7 knockout model.
This suggests that the paralogue gene Pax3 has played a compensatory role for the
loss of Pax7 (Mansouri et al., 1996).

2.4 TRANSCRIPTION FACTORS AND BRAIN DEVELOPMENT
In general, brain development i.e. neurogenesis and gliogenesis, relies on a cascade of
events driven by changes in gene expression profiles of proliferating and
differentiating neuroepithelial cells. These events are steered by transcription factors
which themselves are developmentally regulated. The many known families of
transcription factors involved in developmental processes each have their specific
properties like the structure of the DNA binding domain e.g. the helix-loop-helix
motif that determines the interaction at th"' DNA groove. Transcription factors may be
activated by specific intracellular pathway signalling as a response to cell membrane
receptors and extracellular signalling interactions. On the other hand, they may be
dependent on the binding to other nuclear proteins to influence their activity. In turn
however, all transcription factors alike bind to enhancer and promoter sequences of
downstream genes in a pattern that results in the activation or repression of the genes.
During early neurogenesis, the differences in patterning direct cells to become
committed to the neuronal fate and specified to those cellular phenotypes required for
a particular region. The best studied example of this occurs at the midbrain/hindbrain
boundary after neural tube closure from E8.5 to E12.5.

2. 4.1. The midbrain/hindbrain boundary development
The area designated at the midbrain/hindbrain boundary is known as the isthmus.
During neurogenesis, the isthmus is considered a mid-hindbrain organiser that forms
at the junction of the expression domains of the transcription factors Otx2 and Gbx2
(Fig. 2.5) (Broccoli et al., 1999; Joyner et al., 2000) and the anterior domain of Fgf8
express~on

(Shamim et al., 1999). Otx2 is found expressed in a decreasing gradient

toward the isthmus from the midbrain while Gbx-2 is expressed in a decreasing
gradient from the hindbrain (Joyner et al., 2000). In a developmental cascade Otx2
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induces Pax2 that activates the expression of Enl, which enters a feedback loop with
the signalling molecule Fg/8 that regulates the later expression of Pax5 (Liu and
Joyner, 2001). Pax5 upregulates En2 with a positive feedback loop developing
between the two genes. Enl and En2 expression overlaps that of Pax2 and Pax5
across the isthmus (Joyner, 1996) and Enl, En2 and Pax5 expression is found
throughout the mid/hindbrain boundary region (Liu and Joyner, 2001). The cascades
ultimately result in the formation of the superior and inferior colliculi (as discussed in
section 2.1. 14), posterior midbrain, cerebellum and possible ventral brainstem
(Trokovic et al., 2003).

Signalling molecules from one region have been demonstrated to repress the
signalling molecules from the abutting region with the overlap found at the isthmus.
The Otx2 and Gbx2 border is required to position the expression of the signalling
molecules Wntl and Fg/8. Initially, W n t 1 and Fg/8 are found outside the
mid/hindbrain boundary in the entire midbrain and rhombomere 1 of the hindbrain
respectively but on neural tube closure, Wntl (posterior midbrain) and Fg/8 (anterior
hindbrain) expression becomes restricted to adjacent narrow rings at the isthmus until
embryonic day 12.5 (Liu and Joyner, 2001).

Figure 2.5
Expression patterns at the isthmus of embryonic mouse brain. After neural tube closure, the
transcription factor Otx2 expresses in the presumptive midbrain and the signalling molecule Wntl is
expressed in a narrow ring at the isthmus. The transcription factors Gbx2 and Pax2 express in the
presumptive hindbrain with Pax2 abutting that of Wntl expression (Brown eta!., 2001).
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The important elements involved at the mid/hindbrain boundary are associated with a
regulatory feedback loop that maintains the expression of each other (Shamim et al.,
1999). Gradients of opposing and overlapping expression act by mutual repression to
maintain each regional identity. This is also observed at the mid/forebrain boundary
around the same period ofneurogenesis.

2.4.2. The midbrain/forebrain boundary development
Although the mid/forebrain boundary is not as well described as the mid/hindbrain
boundary, it can serve as another example of how the specific expression patterns of
transcription factors and their interplay influence brain development. The caudal
forebrain is divided into three compartments being the pretectal region, the dorsal
thalamus and the ventral thalamus. Between the midbrain and pretectrun lies the
posterior commissure. On the induction of Pax7 in the midbrain there is a
simultaneous suppression of Pax6 and Pax6 expression is found in the diencephalon
abutting that of Pax7. The anterior boundary of the midbrain is defined by the rostral
Pax7 and the caudal Pax6 expression found in the posterior commissure of the

pretectum (Stoykova and Gruss, 1994). Expression patterns of Pax6 and Pax7 in the
pretectum suggest that they are expressed in different cell populations (Kawakami et
al., 1997; Nomura et al., 1998). The En genes are thought to be transcriptional
repressors, and with a decreasing expression gradient across the midbrain from caudal
high to rostral low, these factors are also thought to repress forebrain genes at the
mid/forebrain boundary. Pax2 is also thought to repress Pax6 at the mid/forebrain
bo~ndary

(Stoykova and Gruss, 1994). Otx2 and Emx2 are factors suggested as

having a developmental function in the forebrain although not in the posterior

commissure (Suda et al., 2001).

2.4.3. Development ofthe superior col/icu!us
Patterning of

th~

early midbrain then allows these committed and specified

neuroepithelial cells to migrate to their final destination and take part in the
organisational phase of specific brain region development. The basic fonnation of the
superior colliculus from sin.·Jle neuroepithelium occurs primarily between Ell-El4.
The mature superior colliculus is composed of seven layers with alternating layers of
fibres and cells, while the formative superior colliculus consists of three primary
layers, the stratum superficiale, the stratum intermedium and stratum profundwn
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(Edwards et al., _986b). From Ell, cells generated in the ventricular zone of the
.nesencephalic neuroepithelium, containing the germinal epithelial cells,

migr?t~

dorsally to the intermediate and marginal zones. The superficial layer is formed after
the deep layers but prior to the completion of the intermediate layer. Superficial and
deep layers are formed from independent cell populations (Edwards et al., 1986b).
Peak cell generation for the superficial layers of the superior colliculus occurs from
E12 (strata opticum) to E13 (stratum griseum superficiale) while the deeper layers are
formed at Ell-E13 (Edwards et al., 1986b). Lamination or the layering of neurons
and fibres in the intermediate and deeper layers begins at E14. By E15, a few retinal
ganglion cell projections have reached the superficial layers and by El? a large
population of retinal ganglion cell axons penetrate all superficial layers concurrent
with the near completion of cell migration (Edwards et al., 1986b).

The lamination process continues until the late embryonic and early postnatal periods
accompanied by a considerable radial growth. At birth there are dense fibre bundles
through all superficial layers but for the first 6 postnatal days these are removed from
the stratum griseum superficia/e (superficial grey layer) while those in the stratum

opticum (optic layer) remain (Edwards et al., 1986b). Simultaneously, collaterals
from axons in the stratum opticum extend and arborise the stratum griseum

superficiale (Edwards et al., 1986a). The topography of retino-tectal projections has
predominantly come from studies performed in chick (Matsunaga, 2001; Nakamura,
2001; Thomas et al., 2004). Generally, axons from the temporal retina project to the
contralateral anterior superior co11iculus while axons from the nasal retina project to
the contralateral posterior superior colliculus (Bahr and Wizenmann, 1996). The
topography of the tectum (the homologue to the superior colliculus in lower
vertebrates) is thought to be formed from signalling molecules expressed as gradients
on retinal axons with opposing gradients on tecta! neurons. The gradient pattern is
thought to be induced by a graded expression of transcription factors e.g. Pax?,
Engrailed, inducing the cell surface Eph and ephrin family to play a predominant role
in axon guidance (Knoll et al., 2001).
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2. 4.4.

Summary

The Stem Cell Leukaemia (Sci) gene encodes a basic

helixMloop~helix

transcription

factor that functions as a cell fate determinant in the haematopoietic system. Sci
expression has been found in the central nervous system, predominantly in the
mesencephalon but also in the diencephalon and metencephalon. A recent Sci gene

deletion study has indicated that Sci is required for normal mid/hindbrain
development. The Sc!-LacZ knockin reporter mouse has been developed for light
microscopy analysi

study the expression pattern of Sci in the brain. Further, a

conditional yellow fluorescent (eYfp) reporter mouse for Sci expression has been
generated using the Cre-loxP system. The mouse is an inducible model that generates
fluorescence in Sc/ expressing cells upon tamoxifen administration. This mouse is
bred for fluorescent and confocal analysis.

The Pax7 gene encodes a transcription factor that contains a DNA binding domain
called the paired box (Pax). Pax? also contains a homeodomain and conserved
octapeptide sequence as well as a transactivation domain. Pax3, with a structure
closely resembling that of Pax7 is thought to offer partial redundancy where
expression domains overlap. The expression pattern of Pax7 suggests a functional
role in the development of the neural crest, skeletal muscle and the central nervous
system. During neurogenesis, Pax7 is part of the cascade that delineates the midbrain
from the forebrain and Pax7 expressing cells are found in the ventricular zone where
they migrate dorsally to the superior colliculus.

Throughout embryogenesis, the expression of transcription factors is developmentally
regulated to maintain differences in specific cell types and tissues. These factors bind
to enhancer and promoter sequences of downstream genes to activate or repress gene
expression. Gradients of opposing and overlapping expression act by mutual
repression to maintain regional identity. This has been observed at the mid/hindbrain
boundary and the mid/forebrain boundary from E8.5 to E12.5. Patterning differences
specify cell commitment and cascades ultimately result in the formation of specific
regions, as the superior colliculus does from the mid/hindbrain boundary.

The Sci and Pax7 genes encode transcription factors that express in the brain during
embryonic neurogenesis, suggesting they may play some organisational role in brain
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development. Both factors continue to express in the dorsal layers of the superior
colliculus in postnatal and adult brain. The spacio-temporal overl:l{) in expression
suggests that Sci and Pax7 may be involved in related functions during brain
development and in the adult brain. This study was undertaken to ascertain whether
Sci and Pax7 were operating within the same cells during early neurogenesi.s through
to adulthood, which then would suggest that they might be part of the same cascade
in the development and/or maintenance of the mesencephalon.
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3. MATERIALS AND METHODS
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3.1 ETIDCAL CONSIDERATIONS

Ethical approval was obtained for this study from the Edith Cowan University
Animal Experimentation Ethics Committee. approval code: 04-A13 and from the
Institute for Child Health Research Animal Experimentation Ethics Committee,
approval code: AEEC #133.

3.2 EXPERIMENTAL PROCEDURES

3.2.1.
•

Mouse Models

The Scl LacZ knockin mouse model on a C57BL/6J background has the LacZ

gene knocked in to the Scllocus so that the expression pattern of Sci can be visualised
for light microscopy once sections have undergone the

•

~-galactosidase

enzyme assay.

The 0.9E3 Cre ER(T) transgenic mouse model on a C57BL/6J background

has Cre recombinase fused to the 5' Sci neural enhancer (0.9E3) as well as an
oestrogen receptor ligand-binding domain. Cre is then produced on the administration
oftamoxifen only in Sci expressing neurons. This inducible model is crossed with the

Rosa26 - eYfp knockin mouse and the double-positive offspring are used for
fluorescent and confocal microscopy analysis.
•

The Rosa26- eYfp knockin mouse model has the enhanced Yellow fluorescent

protein (eYf]l) knocked-in to the Rosa261ocus, a ubiquitous housekeeping gene, to
achieve a high level of fluorescence in all Set expressing cells. A stop sequence
flanked by LoxP sites precedes the Rosa26-e Yfp gene in this knockin mouse. The stop
sequence is cleaved once Cre binds the loxP sites and eYfp is expressed. By crossing
the 0.9E3 CreER(T) mouse with the Rosa26- eYfp knockin mouse, a strong yellow
fluorescent signal is produced in Set expressing neurons. Double-positive offspring
are used for fluorescent and confocal microscopy analysis.

All mice were bred and cared for at the Telethon Institute for Child Health Research
on a 12h/12hr light/dark cycle with water and food available ad libitum.
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3.2.2.

Timedpregnancies

To set up all timed pregnancies, female mice at least 6 weeks old received
intraperitoneal (i.p.) injections of serum gonadotropin (Folligon; 2 units/O.lml PBS,
Intervet Australia) 2 days before mating and with chorionic gonadotropin (Chorulon;
2 units/0.1 ml PBS, Intervet Australia) 48 hours later. Fertile males were then added
to the cage for one night. The following morning an external examination to detect a
plug was performed on the females and the males were removed. For the LacZ timed
pregnancies, both males and females were of heterozygote LacZ/wt genotype and
heterozygote offspring were utilised for experiments. When results were analysed by
fluorescent and confocal microscopy, a 0.9E3 CreER(T) transgenic mouse was
crossed with a homozygous Rosa26- eYfp knockin mouse. Offspring with a double
positive genotype were required to show Sci expression as yellow fluorescence
because in these mice the fluorescent gene e Yfp is activated upon tamoxifen
administration.

3.2.3.

Harvesting embryos

To harvest embryos at specific timepoints, pregnant mice were euthanased at the
required time of pregnancy by cervical dislocation. Embryos were then removed and
placed in PBS, followed by dissection from the uterine horn and yolk sac. The
embryo was decapitated and the head was immersed in 4% paraformaldehyde
(Sigma) fixative for 2 hours on ice and the lower body was used for genotyping. After
fixation of the head, the embryonic tissue underwent three washes in PBS for 15
minutes, followed by immersion in 30% sucrose solution overnight at 4°C. Tissue
was then cryofrozen the following morning in optimum cutting temperature
formulation (OCT Compound; Sakura Finetek, USA) by immersion in liquid
nitrogen.

3.2.4.

Tamoxifen Injections

To induce the expression of e Yfp, 4-hydroxy-tamoxifen (Sigma) in corn oil was
administered by intraperitoneal injection. Adult mice were given 2mg tamoxifen/ 0.2
ml in corn oil each day for 5 consecutive days. A week was then allowed for the
expression of eYfp to accumulate before perfusion of the adult mouse. For the P21
timepoint, mice were given 0.5mg tamoxifen/0.5 ml in com oil for 3 consecutive days
from postnatal day 16. For earlier timepoints, the pregnant female received the
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tamoxifen injections at a concentration of 0.5mg tamoxifen/0.5 m1 in corn oil
administered at El0.5 and lmg!O.lml at Ell.S for the El2.5 timepoint. At the El5.5,
E18.5, E20.5 and P5 timepoints an amount of 1 mg/0.1 m1 tamoxifen was given on
El2 and 2 mg/0.2 ml was given on E13.

3.2. 5.

Cross fostering of tamoxifen treated embryos

To increase the survival of unborn pups from a tamoxifen injected female mouse
during pregnancy, the embryos were born by Caesarean on E20.5 for the P5
timepoints. The pregnant female was euthanased by cervical dislocation to prevent
anaesthetic accumulation in the embryos. The unborn pups were harvested separately,
assisted with the commencement of breathing and wet with excrements from a foster
mother so as to be accepted by the new mother. These new foster mothers were from
an

ARC-Swiss

background

with

white

fur

colour

to

facilitate

recognition/identification from the cross-fostered pups with a dark fur colour in the
new litter.

Timed pregnancies were set up for the foster and the transgenic females so that a
lactating foster mother would be available when the transgenic litter was due to be
born. As the ARC Swiss foster mothers produce large litters they tend to give birth on
E19.S so the ARC Swiss pregnancies were set up a day earlier than the transgenic
mice. At the day of birth, about half of the ARC Swiss litter were culled or given to
other ARC Swiss mothers and replaced by the newborn pups of the transgenic female.
The neonatal care given by the foster mother was monitored for thirty minutes and
followed by regnlar checks throughout the day.

3. 2. 6. Anaesthetic
Anaesthetics (O.lml/!Ogr body weight) were prepared using Ketarnine !OOmg/ml
(Troy Laboratories) in conjunction with Xylazil 1OOmg/ml (Troy Laboratories) and
0.9% saline at a 4:1:5 ratio respectively. Ketamine is a dissociative anaesthetic while
Xylazil provides sedation and analgesia. The anaesthetic was administered using a
needle and syringe by the intraperitoneal (i.p.) route prior to perfusion.
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3.2. 7. DNA Isolation
Genotyping was performed on adult Sci LacZ knock-in and 0.9E3 CreER(T) mice at

weaning age with DNA extracted from a tail tip. Mice were anaesthetised with the
inhalant Methoxyflurane containing an analgesic, for tail tipping. l-2ml of
Methoxyflurane was placed on a cotton wool pad in a bell jar and allowed to

vaporise. The mouse was then placed inside the bell jar until fully anaesthetised. For
the earlier postnatal timepoints, a tail tip was taken after the administration of the
ketamine/xylazil anaesthetic and just prior to perfusion. The lower body of the

embryo was used for genotyping following dissection from the uterine hom.
The tail or embryo sample was placed in an ependorftube and O.Smllysis buffer was
added, made up from O.IM Tris-HCl (pH8.5), 5mM EDTA (pH8.5), 0.5% sodium
dodecyl sulfate, 0.2M NaCl and 82.5% autoclaved MilliQ H20 containing 20mg/ml
Proteinase K (Roche). The tail sample was then digested overnight at 55°C by
shaking at l200rpm in the ependorf thermomixer. The following morning, digested
tails were centrifuged at 13200 rpm for 15 minutes to pellet undigested material. The
supernatant was transferred to a new sterile tube and 0.5ml isopropanol added to each
supernatant/tube. Tubes were mixed by inversion for 20-30 mins until a fine white
pellet was seen floating in solution and then centrifuged at 13200rpm for 14sec. The
isopropanol was poured off and lml 70% ethanol added. The inversion step was
repeated for

20~30mins

and centrifuged at 13200rpm for 14sec. The ethanol was

poured off and any remaining ethanol carefully pipetted out of the tuhe. lOOul of
lOmM Tris-EDTA buffer made up from lOmM Tris-Cl and lmM EDTA (pH 7.4)
was added to each tube and the bottom of the tube was gently flicked about 4 times to
dislodge the pellet from the side of the tube. Samples were shaken at 55°C at
l200rpm in thermomixer for about

l.5~2hours

and then frozen at -20C until PCR was

performed.

3.2.8.

Genotyping ofgenetically manipulated mice using Real-time PCR

Amplified DNA was analysed by

Real~time

PCR assay using molecular beacons that

are DNA hybridisation probes. The beacons have a stem and loop structure with the
loop region being complementary to the target sequence and the stem region
containing complementary arm sequences. Attached to one arm is a fluorescent
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marker and to the other arm a quencher that dissipates energy from the fluorescent
marker (Bustin, 2000). In this study the separate molecular beacons contain probes
with complementary sequences to the LacZ gene (Fig. 3.1) and to the estrogen
receptor region of CreER(T). The real-time primers amplify 1OObp products for both
Real-time PCRs.

Fwd

--;;;--

~._I_M_o_le_cu_lar_ be_a_co_n___.

~ 1--

....

L _ ____.
~Obp product

Figure 3 .I Real-Time PCR primers amplify a I OObp product within the LacZ cassette that has been knocked into
the Set gene. The molecular beacon hybridises to a sequence within the IOObp product and undergoes a
conformational change that results in a fluorescent signal.

The Cre and LacZ Real-time PCR assays included 35 cycles of activation (95° for
600 seconds), denaturation (95°C for 15 seconds), annealing (55°C for 60 seconds)
and extension (72°C for 15 seconds). During the annealing cycle, the molecular
beacon loop underwent a conformational transition while hybridising with the target
(Fig. 3 .2B). Hybridisation forced the stem apart thus separating the fluorophore and
quencher and so creating a fluorescence signal that was detected and quantified
during each cycle by the Real-time PCR machine. The amount of fluorescence
correlated with the amount of amplified product and the genotype was determined
using a threshold value. The threshold value for the LacZ molecular beacon ranged
from 0.05 ·- 0.15 fluorescence with an average of 0.1 while the Cre molecular beacon
ranged from 0.02 - 0.05 fluorescence. The threshold value was reached during the
exponential phase of amplification (>20 cycles), being significantly different from

33

background values (Bustin, 2000). If the fluorescence level was beyond that of the
threshold value then the sample was positive for the specific transgene while a lower
than threshold value meant that the sample was negative for the gene.

Figure 3.2
Real time PCR assay using a molecular beacon. (A) During the denaturation step the
complementary arm sequences of the molecular beacon are denatured and the molecule fluoresces. (8) During the
annealing phase the complementary stems will reanneal and the fluorophore will be quenched. However, in the
presence of the target sequence, molecular beacons will also bind to the target and continue to fluoresce. (C)
During polymerisation, the molecular beacon detaches from the target sequence, the arms reanneal and the
fluorescence is again quenched. The intensity of the fluorescence is measured at the end of each cycle.

Analysis of the LacZ positive animals was done using the molecular beacon (MB)
(MWG Biotech) for LacZ (5' CAC GCG GTG GTC GGC TTA CGG TGA TTT
CGC GTG 3'), a LacZ (MB) forward primer (5' CTG GGA CTG GGT GGA TCA
GT 3') and a LacZ (MB) reverse primer (5' CTG GCG ATC GTT CGG CGT A 3').
The Cre (MB) (5'- CCG GCT CAA GCC CGC TCA TGA TCA AAC GCA GCC GG
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.• 3'), ti1e Cre (MB) forward primer (5'- GAT ere GAG eeA TeT GeT G- 3') and
the Cre (MB) reverse primer (5'- GGT eGG eeG TeA GGG AeA A- 3') were used
to identify the double positive offspring from 0.9E3 CreER(T) transgenic mice

crossed with the Rosa26- e Yfp knockin mice.
3.2.9.

Transcardial Perfusion for the fixation ofbrain tissue

To isolate the brain of neonatal and adult animals, transcardial perfusion was
performed. The ketaruine/Xylazil anaesthetic (O.lml/!Ogr body weight) placed the
mouse into a deep coma and this was confirmed by a tail pinch test, the absence of
corneal reflex and nonnal breathing. A peristaltic pump was used to pump fixative
into the circulation of the mouse via a 25G butterfly needle inserted into the heart.
The blood was first removed by a 40 second phosphate buffered saline (PBS) rinse
and followed by 4% paraformaldehyde (Sigma) in PBS (pH 7.2) kept on ice, for 10
minutes in neonates and 15 minutes in adult mice. Post-fixation was done after brain
dissection in 4% parafonnaldehyde for 30 minutes on ice. Three 15-minute washes in
PBS at room temperature followed post-fixation and then the brain tissue was
cryoprotected in a 30% sucrose/PBS solution at 4°C overnight. (All mice were killed
when the fixative circulated through the brain and body).

3.2. 10.

Ice Hypothermia and transcardial perfUsion ofmouse pups

Ice hypoth~nnia was used as an anaesthetic for the PO mice as they were too small to
undergo i.p. injection. The technique provided immobilisation and mild analgesia and
was effective due to the small surface area and body size. Pups were wrapped in a
tissue to avoid freeze damage to the skin. The tissue was left open at the top to allow
the pup to breathe and then the pup was placed in crushed ice for 3-4 minutes. During
this time the pups became very pale. After performing the tail pinch test to confirm
anaesthesia, transcardial perfusion commenced on a cooling platform to provide a
constant level of hypothermia. Perfusion on pups was performed as described above
for the adult.

3.2.11.

Frozen Blocks

Following overnight cryoprotection in 30% sucrose solution, brain tissue was placed
in cryomold biopsy specimen moulds (Tissue-Tek Cryomold Biopsy) and embedded
with OCT. The moulds were frozen on liquid nitrogen and stored at -80°C for later
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analysis. Frozen tissue was sectioned into 20J,tm serial sections and mounted onto
SuperFrost Plus slides (Menzel-glaser, Germany) using a Leica cryostat (CM3050).

3. 2.12.

LacZ histochemistry

Slides mounted with 20J,tm serial brain sections were air-dried for 30 minutes prior to
the commencement of the LacZ staining procedure. The wash buffer was made just
prior to use from 5mM EGTA (pH 8), 0.01% deoxycholate, 0.02% NP-40, 2mM
MgCh, 20mM Tris (pH 7.3) and lx PBS (pH 7.2). Slides were rinsed in the wash
buffer on the orbital shaker for 3 x 20 minutes with a change of wash buffer each time.
The slides were then incubated at 3rC in the staining solution overnight in a dark
location. The staining solution was made up from the SmM K3Fe(CN)6, SmM
K,Fe(CN) 6 , 5mM EGTA (pH 8), 0.01% deoxycholate, 0.02% NP-40, 2mM MgCh,
20mM Tris (pH 7.3), lx PBS (pH 7.2) and lmg/ml 5-Bromo-4-chloro-3-indolyl

~-D

galactopyranoside (X-gal) (Sigma) inN, N-dimethyl fonnamide (40mg/ml).

The following day, slides were rinsed in PBS for 5 minutes and then dehydrated
through an ethanol series- two minutes each in 70%, 90%, 100% and 100% followed
by two changes in Histoclear (National Diagnostics) for two minu~es each. The slides
were coverslipped in Permount mounting medium (ProScitech) to prevent the LacZ
staining from dissolving. When LacZ histochemistry was followed by
immunoperoxidase staining, dehydration was delayed and immunoperoxidase staining
commenced.

3.2.13.

Immunohistochemistry ofmouse brain tissue for antibodies

raised in mice
The Vector MOM Immunodetection kit (Perth Scientific) was used for the Pax7,
NeuN and Doublecortin (Dcx) antibodies as the kit is specifically designed for
antibodies that have been raised in mice. Slides of 20J,tm serial brain sections were
initially rinsed in PBS for 15 minutes and then the endogenous peroxidases quenched
with a 0.6% H202 in PBS solution for 20 minutes. This was followed by 3 x 15 minute
PBS washes. An avidin block (4 drops of Avidin stock solution in

1000~1

of PBS)

was performed for 15 minutes followed by a 15-minute biotin block (4 drops of Biotin
stock solution in

1000~1

of PBS) using the Vector Avidin/Biotin Blocking Kit, with
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both blocks rinsed afterwards for 5 minutes in PBS. The sections were further
incubated for one hour in the Vector MOM mouse lg blocking reagent (l drop in
1250~1

PBS) and washed 3 x IS minutes in PBS. The primary antibody was added to

the antibody diluent at a concentration of I :I 0 (Pax7), I :500 (NeuN) and I :100 (Dcx).
The antibody diluent was made up from a ratio of 300!11 ofPmtein Concentrate stock
solution (MOM kit) to

3750~-tl

of PBS. The slides were drained of excess fluid and the

primary antibody in antibody diluent added to the sections, covered with parafilm and
incubated overnight in a hwnidified chamber at 4 cc.

The following day, the sections were rinsed 3 x 15 minutes in PBS. The biotinylated
a-mouse IgG reagent secondary antibody was diluted in the antibody diluent at 1:250
and incubated at room temperature for 2 hours. This was then rinsed 3 x 15 minutes in
PBS. Sections were then incubated in the VECTASTAIN Elite ABC reagent (1drop of
reagent A and 1 drop of reagent B to 1250!11 PBS) for one hour at room temperature
followed by 3 x 15 minute washes in PBS. The chromogen diaminobenzidine
tetrahydrachloride (DAB); (DAB Substrate J:(it for Peroxidase, Vector Laboratories)
was made up by adding 1 drop of Buffer Stock Solution to 2500!11 of distilled water
and mixed well. Then 2 drops of DAB Stock Solution were added and mixed followed
by one drop of Hydrogen Peroxide solution, which was added and then mixed. DAB
was visualised for colour from 2-10 minutes and the reaction stopped with the
addition of PBS. Slides were then given 3 x 15 minute washes in PBS, sections
flattened with a brush if required and left to dry for 30 minutes to an hour. The
sections were then dehydrated through an ethanol series- two minutes each in 70%,
90%, 100% and 100% followed by 2 x 2 minutes in Histoclear (Scott Scientific).
Sli<les were then coverslipped with Perrnount to prevent the LacZ staining from
dissolving.

3.2.14.

Immunofluorescence for Pax7

To assess co-localisation of Pax7 and Scl in tissue sections by fluorescent and
confocal microscopy, the following immunofluorescent protocol was performed for
Pax?. Tissue sections were initially rinsed in PBS for 15 minutes followed by an
incubation of the Pax? primary antibody diluted 1:10 in standard antibody diluent of
1% Bovine Serum Albumin (BSA) and 0.2% TritonX-100 in PBS. Sections were
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covered with parafilm and incubated in a dark humidified chamber overnight at 4°C.
The following day, the primary antibody was rinsed with 3 x 15 minute PBS washes
and then the secondary antibody, Cy3 goat a-mouse IgG (Jackson ImmunoResearch
Laboratories), having been diluted in the same standard antibody diluent at 1:300, was
incubated at room temperature for 2 hours. The tissue sections were then given 3 x 15
minute washes in PBS, sections were drained of excess fluid and then coverslipped
using Vectashield Mounting Medium (Vector Laboratories). Nail polish was painted
around the coverslip to seal in the mounting medium and slides were stored in the

dark at 4°C.
3. 2.15.

Microscopic Analysis

Light and fluorescent microscopy was performed on a Leica DMLB microscope and
photographs were taken with a Leica colour digital camera DC300. Confocal analysis
was achieved on a Bio-Rad MRCIOOO confocal microscope at the Centre for
Microscopy and Microanalysis at the University of Western Australia. The aim of this
project was to look at the overlapping expression regions of Sci and Pax7 from
embryonic neurogenesis through to adulthood to assess co-expression between the two
factors. The results reported in this study were not semi-quantitated by cell counting
or density analyses.

3.2.16.

Research Design

Sc/ & Pax7 Co-localisation
The seven different timepoints were selected to follow the expression patterns of Sci
and Pax7 during the formation of the brain and in particular the development and
subsequent innervation and lamination of the superior colliculus. Five to six timed
pregnancies of Scl-LacZ knockin female mice were set up at each timepoint with an
average of two embryonic/early postnatal litters produced. This was

consi~tent

the 40% pregnancy rate previously achieved in the Cancer Biology Lab

with

f,(

the

Telethon Institute for Child Health Research. The resulting litters were tlx:ed vvith 4%

parafonna!dehyde at the timepoints of embryonic day (E) 12.5, El5.5 and El8.5.
Perfusion was performed on two litters of mice at postnatal day (P) 0, PS, at weaning

(P21) and in three adult mice (Fig 3.3). After brain fixation with 4%
paraformaldehyde and overnight cryoprotection in 30% sucrose, the brains were
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cryofrozen in liquid nitrogen and stored at -80°C. Once genotyping had been
performed to detect the presence of the LacZ gene, mouse brains were sectioned at
20!-t-m and mounted on SuperFrost Plus slides. Analysis of ~-galactosidase and Pax7
immunohistochemistry were performed to indicate the expression patterns of Pax7
and LacZ. Sections were also stained with the neuronal cell markers NeuN (Mullen
et al. , 1992) and Doublecortin (Rao & Shetty, 2004) to indicate neuronal subtypes
within regions of co-localisation. Analysis was initially performed using light
microscopy and confirmed by confocal microscopy.

Timed

E12.5 15.5 18.5 PO

P5

P21

Adult

Pregnancies

l

lllll

l

l

Figure 3.3 Timepoints for LacZ co-localisation studies. Timed pregnancies were set up and two litters each from
the E l2.5, E15.5, El8.5, PO, P5 and P21 timepoints were sacrificed for Sci and Pax7 expression studies for light
microscopy analysis. Three adult mice were perfused.

For confirmation of co-localisation usmg confocal microscopy, the fluorescent
transgenic mouse model was used to display the pattern of Scl expressing cells in the
CNS. Inducible 0.9E3 CreER(T) mice were crossed with R26R e Yfp mice so that
fluorescence could be visualised in Sci expressing neurons. Five to six timed
pregnancies were set up with an average of two embryonic/postnatal litters produced
per timepoint. To induce the e YJP expression in the brain, pregnant mice were given
tamoxifen at 0.5mg/0.5 ml at E10.5 and lmg/O.lml at El1.5 for the El2.5 timepoint
and 1 mg/0.1 ml was given on El2.5 and 2 mg/0.2 ml was given on El3.5 for the
E l5.5, E18.5, E20.5 and P5 timepoints. For the P21 timepoint, mice were given
0.5mg/ml in corn oil on P17, Pl8 and Pl9. Adult mice were given 5 daily if1iections
of lmg tamoxifen/ 0.1 ml in corn oil one week prior to perfusion (Fig. 3.4).
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For the PO timepoint, mothers were sacrificed and given a caesarean at E20 as it had
been previously noted that some mothers had difficulty giving birth after tamoxifen
injections. The E20 litters were not perfused but were fixed in 4% paraformaldehyde
as with the earlier embryonic timepoints. For the PS timepoints, mothers were
sacrificed at E20 and after caesarean the pups were cross-fostered to ARC-Swiss
mothers whose time pregnancies had been set up a day earlier. Once these pups
reached PS they were perfused, the brains fixed in 4% paraformaldehyde and then
cryoprotected and cryofrozen. Genotyping was performed by RTPCR of DNA
isolated from tail tips to determine the required genotype, 0.9E3 CreER(Tt, R26R
e YJP +lw. The brains of positively identified animals were then cryosectioned and the
immunofluorescent antibody staining method was performed to detect Pax 7
expression. Microscopic analysis was done using fluorescent microscopy with eYfp
expression detected as yellow autofluorescence and Pax 7 expression as red
fluorescence. The co-localisation of Pax7 and e Yfp expression was assessed with
confocal microscopy. Cells that fluoresced orange were interpreted as cells in which
yellow and red fluorescence had merged therefore co-expressing e Yfp and Pax7.

eYfpTimed

El2.5 15.5 18.5 20.5

Pregnancies

ArcSwiss
timed
pregnancies

P5

Adult

P2l

(Caesarean)

Tamoxifen

Tamoxifen

(O.Smglml Pl7. 18 . 19)

(0.1 mg/ml for 5 days

forP21

prior to perfusion)

for E12.5

Tamoxifen
(I mg/0. 1 ml- El2.5)
(2 mg/0.2 ml - El3.5) for EIS.S. EIB.S. E20. PO and PS

Figure 3.4 Timepoints for e Yfp co-localisation studies. ARC Swiss timed pregnancies were set up a day prior to
the 0.9E3 CreER(T) x GTRosa26 e Yfp. The brown arrows represent the days of embryo harvesting, caesarean
section (E20) and perfusion. The green arrows represent the days oftamoxifen injections for different timepoints.

40

4.RESULTS
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To assess the expression patterns of Sci and Pax7 from embryogenesis into
adulthood, 201J.m brain sections- were stained and analysed at seven different
timepoints from embryonic day (E)l2.5, ElS.S, El8.5, PO, PS, and P2l through to the

adult brain

4.1 LACZ STAINING
The expression pattern of Sci was visualised by light microscopy after the {)galactosidase enzyme assay (LacZ staining) had been performed on sections. The
resulting blue staining was observed as small blue dots in the cytoplasm, possibly
held within the Golgi apparatus as a non-functional protein. The overall Sci
expression pattern was similar to that previously described (van Eekelen et al., 2003).
Embryonic LacZ staining was often found to be weaker than staining in postnatal and
adult brain regions. As embryonic tissue was not perfused, the 4% paraformaldehyde
did not enter the circulation and so the difference in brain fixation may have possibly
affected the quality ofLacZ staining.

LacZ staining could be combined with Pax? immunoperoxidase staining for light
microscopy analysis. However, background produced by the peroxidase reaction used
to detect Pax? was too high if the combined staining procedure was performed on
embryonic tissue. Moreover, in postnatal tissue where Pax? expression was most
intense in dorsal superior colliculus, LacZ staining seemed compromised when
combined with Pax? immunohistochemistry. This occurred at the PO and PS
timepoints with the LacZ staining found paler when compared to controls. Strong
blue staining was observed expressed in other brain regions on the same section but
high magnification was needed to detect LacZ within dorsal superior colliculus. As
the LacZ staining was not affected in tissue regions where Pax? expression was not
found then the paler staining is unlikely to be a technical problem (personal
observation).

4.2

PAX? STAIN!NG

Pax7 immunoperoxidase staining was observed as specific nuclear staining at all
timepoints. The increased background observed at embryonic timepoints may be
explained by differences in tissue, perhaps from increased amounts of peroxidases
found within embryonic tissue. The observed expression pattern of Pax? has been
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partially detailed in a previous report (StoykOva and Gruss, 1994). Experiments
performed here have greatly extended knowledge of the Pax7 expression profile
throughout diencephalon, mesencephalon and metencephalon at several timepoints
during development and postnatally.

4.3 FLUORESCENT AND CONFOCAL MICROSCOPY
With Pax7 expression observed as nuclear staining and Sci expression as small blue
dots in the cytoplasm, co-expression could not be confirmed by light microscopy.
Although within a large population of the cells co-expression appeared likely, the
adjacent blue staining may have come from an adjoining cell or one sitting directly
above the Pax7 expressing cell. Confirmation of co-localisation was therefore
assessed by confocal microscopy that analysed sections at different focal depths. The
series of virtual sections along the Z-axis were then overlayed for 3D visualisation
using the Comas software. eYfp fluorescence reflecting the Set expression pattern
was seen under a fluorescent microscope as green nuclear staining while Pax?
expression was seen as red nuclear staining. When detecting the cell co-expression of
eYfp and Pax? under the confocal microscope, orange cells were observed from the
merging of cellular expression whereas adjacent cells expressing eYfp and Pax?
remained green and red. Unfortunately at most embryonic timepoints, the eYfp
fluorescent signal did not reach the threshold levels necessary to visualise specific
nuclear staining and so co-expression could not be confirmed at some of the earlier
timepoints. The lower than threshold fluorescence was probably a result of the
reduced timeframe in which the embryo had to generate fluorescence after tamoxifen
administration. The tamoxifen was also given. in reduced concentrations so as not to
be detrimental to the embryos. The best fluorescent results for the eYfp protein were
seen in the adult brain after five days of tamoxifen administration and a week was
allowed for the accumulation of the fluorescence protein. However, in most cases the
expression patterns of Sci and Pax7 during embryonic neurogenesis were not found in
the same regions and co-localisation was not suggested.

4.4 NEURONAL MARKERS
Some sets of sections having undergone LacZ histochemistry were also stained for
the neuronal markers Doublecortin (Dcx) and Neuronal Nuclear Protein (NeuN) in
order to identify the neuronal cell phenotype. Within the brain, NeuN is neuronal
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..
cell-type specific and its expression initially appears at a time between the neuron
progenitor cell leaving the proliferative phase of neurogenesis and the
commencement of terminal differentiation. The expression continues in the mature

fully differentiated neuron. In most neurons, NeuN immunoreactivity stains the
nucleus however staining has been observed in the cytoplasm and even the processes
of some neurons (Mullen et al., 1992). The neuronal marker Doublecortin (Dcx) is a

microtubule-associated phosphoprotein (MAP) that is used as a marker to identify
newly born neurons (Rao, 2004). The expression of Dcx is found in cells that are
tangentially migrating with the strongest signal seen in both the soma and the leading
processes of neurons (Francis et at., 1999). Dcx expression continues in the neuron
during differentiation including the early growth period where dendritic and axonal
growth is taking place. Some degree of overlap has been observed between Dcx and
the mature neuron marker NeuN owing to the extended period of expression of Dcx.
(Rao, 2004). Dcx expression normally ceases within 21 days after the birth of the
neuron (Francis et al., 1999).

In this study, at the P21 timepoint, possible co-localisation of Sci with NeuN was
seen in the superior colliculus but not in all cells as observed in the adult brain.
Possible Sci co-localisation with Double-cortin (Dcx) in the dorsal superior
colliculus, rostral inferior colliculus, the lateral interpeduncular nucleus and the
posterior hypothalamic area was also observed whereas the control slide showed no
specific staining. This would suggest that not all Sci expressing cells had fully
differentiated into mature neurons at this time and some were still in an immature
neuron state as indicated by their possible co-localisation with Dcx. .However,
neurogenesis is thought to be complete a few days prior to birth and the Dcx marker is
meant to cease expression within 21 days after the birth of the cell. Our observation
may indicate that Dcx was expressed for longer than 21 days after the birth of the cell
which contradicts the current literature (Rao, 2004). On the other hand it may suggest
that neurogenesis still occurs at a later stage than originally thought for which we do
not have any further evidence. Maybe the most likely explanation would be that the
staining observed was not indicative of Dcx expression for some technical reason.
Unfortunately we were unable to co-stain NeuN and Dcx with Pax7 as the primary
antibodies are all monoclonal and raised in mouse and therefore cannot be
differentiated from each other with the a-mouse secondary antibody in the
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Neuronal
Markers

Figure 4.1 Expression patterns of Sci (blue) and NeuN (brown) at the P2 1 (A and B) and the PS timepoints (C).
Photomicrograph A illustrates Sci and Ne uN staining in the superior colliculus and shows evidence of colocalisation in the vast majority of ce ll s but not all.

Photom icrograph B is a lower magn ificatio n of A.

Fig ure 4.2 Express io n patterns of Sci (b lue) and the immature ne uronal marker Dcx (brown).
Photomicrograph A implies co-localisation between Sci and Dcx in the s uperior colliculus in nearly every

Sci expressing cell at the P2 1 timepo int. Pho tomicrograph B is a lower magnificat io n of A.
Photomicrograoh C illustrates oossible co-localisation between Sci and Dcx in the interoeduncular region

,.
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immunohistochemical staining procedure. Immunohistochemistry using mouse
monoclonal antibodies in a sequential manner has previously been performed but the
results have displayed ambiguity. Dcx staining at the embryonic timepoints resulted
in a great deal of background that did not allow for specific analysis whereas the
postnatal staining was more effective and was found to co-localise with Scl. The
neuronal marker co-staining was not pursued as the results were inconsistent, they
could not be performed in combination with Pax? and therefore they did not add to
this research.

4.5 MAPPING OF EXPRESSION PATTERNS IN THE BRAIN
The expression patterns were determined in the adult and P21 brains using the
Paxinos and Franklin mouse brain atlas (Paxinos and Franklin, 2001). For the earlier
timepoint, mapping was established with the aid of prenatal mouse brain atlas
(Schambra et al., 1992). The P21 and adult brain expression patterns were found to be
the same and· so wi11 be described and discussed as one timepoint. Unfortunately,
there is no brain map available for the early postnatal period. Despite the fact that the
anatomy of the P5 brain has not fully matured at this age, the adult mouse atlas was
used in the absence of a better alternative. For analysis of the PO timepoint, the
embryonic day 18 map was utilised. All analysis was done in the saggital plane and
postnatal expression patterns have been described firstly at the midsaggitallevel close
to midline. The description then extends laterally to the midpoint of one hemisphere
followed by the most lateral expression domains of Scl and Pax?. As the embryonic
brain is smaller, the description of expression patterns is all encompassing.

As the Sci expression pattern is more extensive and described in great detail by van
Eekelen et al (2003), the description in these results will only depict regions of
expression where Scl and Pax? are both found and where there is expression variation
between different timepoints. During brain development, four main brain regions will
be discussed where both Scl and Pax? are expressed.
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E12.5
timepoint

Fig ure 4.1 Expression patterns of Sci and Pax 7 at E 12.5. The schematic drawing in the centre represents

Sci (blue) and Pax7 (pink). Indicated frames labelled A-C refer to the location of photomicrographs
inc luded in this figure. Photomicrograph A illustrates Sci expression in the posterior commissure (PC)
and developing pretectum (PT) as analysed by confocal microscopy (indicated by yellow/green staining
in the cell cytoplasm). Note some early migratory Pax7 positive cells indicated by red stai ning in cell
nucleus (arrows). Bright red staining of pia is cons idered non-specific. No co-localisation of Pax7 and
Sci based on the absence of red and gree n staining merged to orange is evident in this reg ion.
Photomicrograph B highlights Pax7 expression in the subthalamus (SUT) and pons (PN) region around
th e mesencephalic flexure (MF) as analysed by confocal microscopy. Photomicrograph C l a nd C2
illustrate Pax7 ex pression. in the isthmus ( IS) as analysed by confocal microscopy (CJ) a nd light
microscopy (C2), with brown nuclear immunoreactivity.
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As several different maps have been utilised to describe expression patterns, often
these regions have structures that are different by name according to their level of
development. For ease of identification, especially in the embryonic brain they will be
described as the tectum (developing superior colliculus), the developing pretectal area
and the developing tegmentum and rostral hindbrain.

4.6 E12.5 TIMEPOINT
Peak cell generation occurs between E12 to El3 for the superficial layers of the
superior colliculus during embryonic neurogenesis (Edwards et al., l986b). Pax7 was
not found in the developing tectum (superior colliculus) at this timepoint but was seen
in a small region of the subthalamus and in a broad expression region of high
intensity within the isthmus (Fig. 4.IB). Dorsally, Sci expression was found in the
developing tectum at the most dorsal layer, the posterior commissure, pretectum (Fig.
4.1A) and the tegmentum. The overlap ofScl and Pax7 was seen in the region of the
isthmus but with no indication of co-localisation after confocal analysis. These results
were confirmed in three separate mice by performing both (immuno)histochemical
and immunofluorescent staining for light microscopy and confocal microscopy. 139
sections underwent (immuno)histochemical staining for the mapping analysis at the
El2.5 timepoint.

4.7 E15.5 TIMEPOINT
At El5.5, retinal ganglion cell projections are beginning to innervate the superficial
layers of the superior colliculus (Edwards et al., 1986b). At this timepoint, Pax7
showed high expression in the dorsal ventricular zone with Pax7 expressed in nearly
every cell. From this region, scattered Pax7 expressing cells were seen to migrate
dorsally into the tectum from the ventricular zone (Fig. 4.2B). The scattered
migrating cells were found throughout the superior colliculus and inferior colliculus.

Pax7 expression was also found in the rostral hindbrain in the region ventral to the
dorsal raphe between the mesencephalic flexure and the aqueduct (Fig. 4.2C). More
rostral, a small region of Pax7 expression was found in the caudal thalamus.
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E15.5
timepoint

AQ

4V

Figure 4 .2 Expression patterns of Sci and Pax7 at E 15.5. The schematic drawing in the centre represents
Sci (blue) and Pax 7 (pink). Indicated frames labelled A-D refer to the location of photomicrographs
included in this figure. Photomicrograph A illustrates possible co-localisation of Sci and Pax7 within the
developin g pretectum (PT). Co-localisation could not be confirmed in this region w ith confo cal
microscopic analysis, as thee Yfp thresho ld was not reached. Photomicrograph B illustrates a high level of
Sci express ion in the most dorsal layer of the superior colliculus (DSC) while Pax7 is expressed in nearly
every cell in the dorsal ventricular zone. Scattered Pax7 cells are observed mi grating dorsally.
Photomicrograph C illustrates fluorescent Pax7 staining between the mesencephalic flexure (MF) and the
aqueduct (AQ). Photomicrograph D 1 finds Pax7 and Sci expression overlapping in the tegmental region
with Sci in caudal tegmentum and rostral hindbrain (RH) lining the fourth ventri cle (4V) and Pax7
. extending into the developing rostral hindbrain. Photomicrograph D2 is the higher magnification of D I
showing the overlap but not co-localisation of Sci and Pax7.
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Sci expression displayed a high level of expression in the most dorsal layer of the
superi1>r colliculus and was also found expressed in the inferior colliculus. Sci
expression was seen in the subventricular zone of the dorsal tegmentum. No

co~

localisation between Sci and Pax7 was indicated in the superior colliculus at this
timepoint. Similarly, Expression of both Sci and Pax 7 showed possible colocalisation within the developing pretectum in the posterior commissure (Fig. 4.2A)
but with no co-expression in the developing tegmental region (Fig. 4.2D 1, D2). These
results were confirmed after performing (immuno)histochemical and
immunofluorescent staining on three separate mice. 261 brain sections were
(immuno)histochemically stained for the E15.5 mapping analysis.

4.8 E18.5 TIMEPOINT
In the superior colliculus at E18.5, a large population of retinal ganglion cell axons
have penetrated all the superficial layers, and cell migration from the ventricular zone
to the superior colliculus is almost complete (Edwards et al., 1986b; Edwards et al.,
1986a). In similar patterning to that at El5.5, Pax? expression was seen scattered
throughout the developing superior colliculus (Fig. 4.3B) extending to the inferior
colliculus. Pax7 expression also extended from the interpeduncular region (Fig.
4.3D2) to the rostral hindbrain region along the fourth ventricle crossing the
preswnptive median raphe region in the tegmentum. Pax? was again found expressed
in the caudal thalamus (Fig. 4.3C).

Sci expression was seen in the dorsal most layer of the superior colliculus close to the

midline (Fig4.3B). At the level of the dorsal raphe, Sci was found in the dorsal region
while Pax? was seen in the ventral area. The rostral hindbrain region displayed
overlapping expression but with no co-expression. For expression patterns at El8.5
three mouse brains were utilised for light microscopy analysis and two were utilised
for fluorescent and confocal microscopy. A total of 132 brain sections were
immunostained at the El8.5 timepoint.

4.9 PO TIMEPOINT
The PO timepoint is a time of great activity within the superior colliculus as
previously described in the literature. Innervation of the retinal axons is near
completion and the superior coiliculus undergoes extensive radial growth.
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E18.5

timepoint

DSC

Figure 4.3 Expression patterns of Sci and Pax7 at E 18.5. The schematic drawing in the centre represents Sci
(blue) and Pax7 (p ink). Indicated frames labelled A-D refer to the location of photomicrographs included in
this figure. Photomicrograph A I displays Pax7 fluorescent staining in the developing pretectum (PT) and A2
illustrates Sci LacZ staining in the same region using light microscopy. Photomicrograph B illustrates high
density Sci expression in the dorsal superior colliculus (DSC) and evenly scattered Pax7 staining throughout
the superior colliculus extending to the inferior colliculus (IC). Photomicrograph C illustrates the small
expression area of Pax7 in rostral thalamus with fluorescent staining. Photomicrograph 01 disp lays Pax7
fluorescent staining in the interpeduncular (JPL) region extending toward the fourth ventricle and 02 illustrates
Pax7 and Sci expression surrounding the mesencephalic flexure (Mf) with Pax7 expression in caudal thalamus
(TH) and the interpeduncular region. There is no co-local isation suggested between the t wo expression
patterns at this timepoint.
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Figure 4.4 Expression patterns of Sci at E20.5 and Pax7 at PO. The schematic drawing in the centre
represents Sci (blue) and Pax7 (pink). Indicated frames labelled A-D refer to the location of
photomicrographs included in this figure. Photomicrograph A illustrates a strong band of Pax7
expression in the pretectum (PT). Photomicrograph B I shows Pax7 and Sci in the dorsal superior
colliculus (SC). Pax7 expression is in high density throughout the dorsal superior colliculus at this
timepoint and extensively throughout all the superior colliculus layers Photomicrograph 82 is a higher
magnification of B l. Note the pale LacZ staining amongst the dense Pax7 staining. Photomicrograph C
illustrates an overview of Pax7 fluorescent staining in caudal superior colliculus and in rostral hindbrain
showing expression along the almost mature mid/hindbrain boundary. Photomicrograph D shows the
high density fluorescent Pax7 staining between the interpeduncular (IPL) nucleus and the fourth ventricle
· (4V).

52

At this stage dense fibre bundles are present throughout all layers of the superior
colliculus (Edwards et al., 1986b). Similar expression patterns were seen for Pax7 at
PO as in the earlier timepoints but with extensive Pax7 expression found throughout
the superior colliculus and high density staining found within the dorsal layers (Fig.
4.481, 82). In rostral hindbrain, Paxl expression was found in the rostral part of the
dorsal tegmental nucleus and caudal dorsal raphe (Fig. 4.4C). Paxl expression was
also found ventral and within the interpeduncular nucleus (Fig. 4.4D). Paxl
expression continued to be seen in a line of expressing cells from the mesencephalic
flexure to the fourth ventricle along the almost mature mid/hindbrain boundary. The
confined circle of Paxl expression consistently seen from the E12.5 timepoint was
again found in the ventral thalamic region.

At PO, Sci expression in the superior colliculus increased into the deeper layers but
not to the same extent as that observed for Pax7 expression in this region Sc/ was
found more restricted to the most dorsal layers extending to the pretectum at a close
to mid-saggital level. Sci was also found in the dorsal tegmental nucleus and the
dorsal raphe where expression overlapped that of Paxl but did not co-localise. A line
of expressing cells for both factors was seen rostral to the dorsal raphe with a degree
of overlap near the third ventricle. At sections more lateral from midline, Sci and

Pax7 expression became denser in the pretectum (Fig. 4.4A). In the most lateral
sections displaying both factors, Sc/ was again limited to the most dorsal layer of the
superior colliculus while Pax7 expression remained extensive throughout the superior
colliculus with a high density seen in the dorsal layers. For analysis at the PO
timepoint, three mouse brains were assessed using light microscopy and two mouse
brains at E20.5 were assessed with fluorescent 311d confocal microscopy. In all, 217
brain sections were (immuno)histochemically stained for the mapping at the PO
time point.

4.10

PS TIMEPOINT

During the early postnatal period there is considerable radial growth in the superior
colliculus and for the first 6 postnatal days fibre bundles are removed from the
superficial grey layer while those in the optic layer remain. At the sa."!le time,
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P5
timepoint

PT

PT

lPL

Figure 4.5 Expression patterns of Sci and Pax7 at PS. The schematic drawing in the centre represents Sci
(b lue) a nd Pax7 (pink). Indicated frames labelled A-D refer to location of photomicrographs included in
this figure. Photomicrograph A illustrates fluorescent Pax7 staining in the pretectum. Photomicrograph 8 I
displays Pax7 fluorescent staining with extensive expression throughout the superior colliculus (SC). Note
the rostro-caudal bands of Pax7 expression seen within the layers of the superior colliculus in fluorescent
and 82 in light microscopy of Pax 7 and Set staining in the supe rior colliculus. Photomicrograph C
illustrates the Pax7 and Sci overlapping expression in the region of th e laterodorsal tegmental nucleus
without co-expression. Photomicrograph D I shows fluorescent Pax 7 staining at the interpeduncular
nucleus (TPL) and 02, light microscopy of Pax7 expression seen from the interpeduncular nucleus to the
fourth ventricle.
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connections from axons in the optic layer extend and arborise the superficial grey

layer (Edwards et al., 1986b).
Strong Pax7 expression was found in the superficial layers (zonal, superficial grey
and optic layer) of the superior colliculus and a medium density expression was found
throughout the intennediate and deeper layers (Fig. 4.5Bl, B2). Rostra-caudal bands
of Pax7 expression were seen within the layers of the superior colliculus. This is
probably an indication that lamination has occurred. Unfortunately without a specific
map for the PS timepoint, it was difficult to ascertain the ~recise layers of the superior
colliculus where the rostra-caudal bands were found expressed. The caudal high,
rostral low gradient across the dorsal layers of the superior colliculus and the dorsal
high, ventral low gradient across the superior colliculus (Fig. 4.6A4) was seen as
described by Thomas et al, 2004. A strong pretectal expression (Fig. 4.5A) was also
observed and a stream of stained cells seen expressed from the interpeduncular
nucleus (Fig. 4.501) to the fourth ventricle (Fig. 4.5D2) although much narrower
than seen at earlier timepoints. The similar circle of Pax7 expression was again found
in the caudal thalamic area of the posterior hypothalamus.

Scl expression was found more widespread within the superior colliculus at this
timepoint (Fig. 4.5B2) and Sci was also found expressed in the cortex of the inferior
colliculus. A strong pretectal expression was observed with possible co-localisation
between Sci and Pax7. Scattered Sci cells were found dorsal to the line of Pax7
expression from the interpeduncular nucleus to the fourth ventricle crossing median
raphe but with no evidence of co-localisation. Both factors were expressed in the
interpeduncular nucleus but again with no co-localisation confirmed. Overlapping
expressions for Scl and Pax7 was also found in the laterodorsal tegmental nucleus
(Fig. 4.5C) with Pax7 expressing ventrally and Sci dorsally with no indication of colocalisation. For analysis at the PS timepoint, three mouse brains were assessed for
light microscopy and three for fluorescent and confocal microscopy. 175 brain
sections were (immuno)histochemically stained for light microscopy mapping
analysis for the PS timepoint.
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P21 and
adult

4V

Figure 4.6Expression patterns of Sci and Pax7 at P21 and in the adult brain. Both timepoints are taken
together as the expression patterns and morphology at P21 and in adult b rain was found alike. The
schematic drawing in the centre represents Sci (blue) and Pax7 (pink). Indicaned frames labelled A-B refer
to the location of photomicrographs included in this figure. Pax 7 expression is restricted to the dorsal
midbrain and a small region of expression in rostral hindbrain at these time.p oints. Photomicrograph A I
illustrates Sci and Pax7 expression in the dorsal layers of the superior collic ulus indicating possib le colocalisation. Photomicrograph A2 is highe r magnification of A I. Photomicrograph A3 displays P21
confocal analysis of a high population of cells within the dorsal superior collliculus co-local ising Sci and
Pax7. (Sci - green, Pax7 - red, co-localisation - orange) Photomicrograph A4 showing a strong Pax7
fluorescent s ignal seen in a caudal high, rostral low gradient in the dorsal layers of the superior colliculus.
Photomicrograph B illustrat es the overlapping but not co- localising Sci a nd Pax7 ex pression at the
laterodorsal tegmentum (LDTg). This expression region in the rostral hindbrain is reduced from that at
earlier timepoints.
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4.11

P21 AND ADULT TIMEPOINT

Remarkably. the expression patterns at postnatal day 21 and in the adult brain were

found to be the same in every region for both Sci and Pax?. Pax? expression was
found in a more restricted expression domain than that of Sci in the mature mouse
brain.

Pax7 was also reduced when compared to the Pax? embryonic expression pattern
although with continued high expression in the dorsal superior colliculus. Expression
was found within the superior colliculus, a few Pax? cells were found expressed in

the inferior colliculus, the medial pretectal nucleus, the tegmentum and
interpeduncular nucleus. Pux7 was no longer found expressed in caudal thalamus or
in a line of expression from mesencephalic flexure to the fourth ventricle. The caudal
high, rostral low gradient across the dorsal layers of the superior colliculus and the
dorsal high, ventral low gradient across the superior colliculus continued in the
mature brain. Pax7 expression was also found ventral to the laterodorsal tegmentum
(Fig. 4.6B) and in the rostral part of the lateral interpeduncular nucleus. In sections
further from the midsaggital cut, Pax7 expression became limited to the superior
colliculus.

Sci was found evenly expressed across the superficial grey layers of the superior
colliculus in a high density (Fig. 4.6Al, A2). A gradient of decreasing density was
observed from dorsal to ventral in the superior colliculus. Sci was expressed
throughout cortical regions of the inferior colliculus. Outside the superior colliculus,

Sci expression extended in more lateral sections than that of Pax7, mainly in the
inferior colliculus and ventral midbrain region. In pretectum, Sci expression extended
to the precommissural nucleus and parafascicular thalamic nucleus. In rostral
hindbrain, Sci was also found expressed in the laterodorsal tegmentum (Fig. 4.68).
Co-localisation was indicated by light microscopy in the dorsal superior colliculus
with a high density of co~expressing neurons found in the superficial grey layer (Fig.
4.6Al, A2). Confocal analysis confirmed that a high population of cells within the
dorsal superior colliculus did co~express Sci and Pax7 (Fig. 4.6A3). Although it
would be useful to quantify the degree of co~expression in this area, confocal analysis
does not allow for this as the laser bleaches the fluorescent signal and the light
microscopy model carmot accurately enough determine those cells that co~express the
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two factors. Both factors were also found to be expressed in the lateral
interpeduncular nucleus. But here co-expression was excluded as Pax7 expression
was found in the rostral part of the lateral interpeduncular nucleus and Sci found in
the ventrocaudal part of the lateral interpeduncular nucleus. For analysis at both the
P21 and adult timepoints, two P21 and two adult mouse brains were utilised for light
microscopy while one for each timepoint wa!l analysed for fluorescent and confocal
microscopy. For the P21 timepoint, 180 brain sections were (irnmuno)histochemically
stained and 234 brain sections were stained and analysed under light microscopy for
the adult brain analysis.

In summary, the expression pattern of both Pax7 and Sci each remained relatively
consistent during the process of development from E 12.5 until adulthood.
Comparative analysis of the two patterns over time reveals the partial overlap
particularly in the developing pretectum, tectum and specific rostral hindbrain
regions. However, the most striking result was that co-expression was only confirmed
in the mature superior colliculus, specifically in the dorsal visual layers of the
midbrain structure.
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5. DISCUSSION
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5.1 NEW FINDINGS IN TillS STUDY
The major result from this study was that Pax? and Sci were found to co-localise

within a subpopulation of postmitotic cells in the mature superior colliculus but with
no evidence for this during embryogenesis, although co-expression in the pretectum
before birth cannot be excluded. This contrasting outcome was striking because based
on the preliminary studies in adult tissue, co-localisation behveen Sci and Paxl

during brain development bad been anticipated.
5.2 CHANGE OF FUNCTION OVER TIME FOR PAX7 AND
SCL
In contrast to a range of neurogenic transcription factors which cease to be expressed
after neurogenesis, like ta/2 (Bucher et al., 2000) and mash I (Lo et al., 1991) among

others, Sci and Paxl continue to be expressed in the adult brain. This unperturbed
expression over time suggests a possible change in function from playing a crucial
role in neuronal differentiation before birth (Kawakami et al., 1997) to one of
maintenance of a fully differentiated cellular phenotype within the dorsal layers of the
superior colliculus in the adult brain.

My observation that Sci and Pax? were not found in the same cells during embryonic
neurogenesis, whereas they were found

co~expressed

in the same cells of the fully

developed brain is likely to support this proposed change in function of Pax? and Sci
over time. A described molecular mechanism which would allow a change of
function of transcription factor Sci over time and/or in different cells based on the
finding that Scl acts as a gene regulatory protein within a multiprotein complex.
Depending on the nuclear protein partners within such a complex, Sci is known to
influence the expression of different downstream genes in different cell types (Begley
and Green, 1999; Lecuyer and Hoang, 2004). Although less is known about the
molecular mechanism of action of Pax7 at the level of the DNA, a similar principle
cannot be excluded. Thus, combinations of specifically

co~expressed

transcription

proteins form multifactorial complexes that transcriptionally regulate other proteins.
Expression changes of these factors may alter the target or the function of a complex
and the loss of one factor may prevent the complex from forming (Lecuyer and
Hoang, 2004). Such a disruption of a gene regulatory event during brain development
may have consequences for the cascade of these events, which underlie proper
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development of the central nervous system (Anderson, 1997). In this study, it may be
that in the cascade of events defining embryonic neurogenesis in the tectwn, Sci is
downstream of Pax?, as Pax? expression is evident in the majority of proliferating
neural stem cells in the ventricular zone of the aqueduct, where no Sci has been
detected so far (this study; van Eekelen et al., 2003). If so, the absence of postmitotic
embryonic tectal cells expressing both Sci and Pax? may then imply that Sci
expression is permitted only if the Pax? expression is downregulated after
proliferation. Alternatively, those cells that remain positive for Paxl and have been
observed migrating from the ventricular zone to the dorsal tectallayers do not allow
the expression of Sci. On the other hand, expression of different isofonns or splicing
variants of Paxl and Sci would allow different functioning in different cells and
tissues. A series ofisofonns for both Paxl (Ziman et al., 2001a) and Sci (Calkhoven
et al., 2002) have been reported but it is not known which isoform is present at what
timepoint or in what region. Finally, the presence of a specific DNA binding
sequence for Sci, the E-box in the Paxl gene suggests the theoretical feasibility that
Sci could regulate the expression of Paxl (Nielsen, 1996; Begley and Green, 1999;

Lecuyer and Hoang, 2004). Although this study does not provide the evidence for any
of these mechanisms of action to happen, the possibility of a change in function over
time is strongly implied by my observed alteration from expression of Pax? and Sci
in different embryonic neurons to co-expression after maturation of the brain.

In recent times it has been suggested that neurogenesis is taking place within the adult
brain. This is generally accepted to be occ\Jrring in the dentate gyrus and the
subventricular zone (Arvidsson et al., 2002; Fabel et al., 2003; Jin et al., 2003;
Montaron et al., 2003; Perez-Martinet al., 2003; Yoshimura et al., 2003). Other
studies have explored alternate regions for evidence of adult neurogenesis (Lie eta!.,
2002; Zhao e! al., 2003) with the latter finding progenitor cells in the substantia nigra
suggesting that o. basal replacement of neurons is taking place. Although the role of

Paxl during emt..!'!'onic neurogenesis involves the proliferation and early
specification of neural 5:em cells, it seems unlikely that in the adult brain with Pax?
expression observed in such a large number of scattered cells in the superior
colliculus, these cells would indeed be neural stem cells undergoing continual
regeneration. With the close proximity of the dentate gyrus to the superior colliculus,
in histochemically analysed sections, studies based on the analysis of BrdU
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incorporation into dividing cells being either neural stem cells or progenitor cells in

the CNS (Arvidsson eta!., 2002; Hellston, 2002; Fabel eta!., 2003; Jin eta!., 2003;
Yoshimura et al., 2003) should have identified a high population of ceHs turning over
within the superior colliculus ifneurogenesis were occurring to such an extent.

Co-localisation of neural marker NeuN in every Sci expressing cell in adult brain
indicates that Sci is expressed in neurons (van Eekelen et al., 2003). With
confinnation of the co-localisation of Sci and Pax7 in the dorsal superior colliculus,
this would indicate indirect but convincing evidence that in co-localised cells, Pax7 is
also expressed in neurons. This has not previously been determined as both Pax? and
NeuN antibodies are raised in the same species (mouse) and cannot be differentiated
by the anti-mouse secondary antibody used in immunohistochemical analysis. If we
are to believe that NeuN is indeed a mature neuronal marker, then the expression of

Pax7 in mature

~eurons

is also further indication that it is unlikely that Pax7

expressing cells in mature superior colliculus contribute to adult neurogenesis.

5,3 DYNAMIC EMBRYONIC EXPRESSION PATTERNS OF
PAX7 ANDSCL
Infonnation derived from knockout studies (Mansouri et al., 1996; Bradley et al., to
be submitted) has shown that both Pax7 and Sci are important neurogenic factors.
Surprisingly in the embryonic tectum and developing superior colliculus there is no
co-localisation found between the two factors. From E15.5, Pax7 is expressed in the
dorsal ventricular zone in nearly every cell. Here stained cells are seen migrating to
the developing tectum. Pax7 expression may be involved in the proliferation and
early specification of newborn cells and in the persistence of the ventricular zone at
this stage. At PO and P5, extensive Pax7 expression is seen across the superior
colliculus with high density staining in the dorsal layers coinciding with a time of
considerable radial growth and the removal of fibre bundles from the superficial grey
layer of the superior colliculus. Sci expression on the other hand is found in the
intennediate and marginal zone of the tectum and tegmentwn at E12.5 neighbouring
the ventricular zone. By E 15.5 and E 18.5, the Sci expression pattern is confined to the
most dorsal layer of the superior colliculus. This highly specific and non-overlapping
expression pattern of Pax7 and Sci may suggest that Sci and Pax7 have similar roles
in neuronal subtype sp~cification in the presumptive superior colliculus/tectum.
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However, they do not seem to exert this similar function in the same cells. It is likely
that Sci and Pax? are involved in the neuronal differentiation of different
subpopulations of neurons during tecta! development.

Pax? has been described as a detenninant in the mid/forebrain boundacy fonnation in
the embryonic brain (Kawakami et at., 1997; Nomura et al., 1998) where it is
involved in a mutually repressive role with Pax6. The region of overlap between

Pax6 and Pax7 (Stoykova and Gruss, 1994) is found in the posterior commissure. Scl
is also found in the posterior commissure possibly co-expressing with Pax? although
confirmation was technically not possible (discussed later in this discussion). If there
is co-localisation between Pax7 and Sc/ then this may imply that both factors are
involved in boundary formation between the thalamus and midbrain.

Similar overlap of Sci and Pax7 expression was seen in the isthmus or wider
mid/hindbrain region stretching from the mesencephalic flexure to tegmental and
rostral hindbrain regions bordering the fourth ventricle. Interestingly, in this
organising region Pax? is found expressed in rostral hindbrain and not midbrain. This
is surprising as Pax7 is described as a factor involved in the delineation, polarisation
and regionalisation of the midbrain (Jostes et al., 1990; Stoykova and Gruss, 1994;
Kawakami et a!., 1997). With the lack of a detailed Pax7 map this might have raised
expectations in the past that Pax7 would be found expressed on the midbrain side of
the boundary.

5.4 GENERATION OF AN EXPRESSION MAP FOR P AX7
To investigate the potential co-expression of Pax7 and Sci, a detailed mouse brain
map was required and generated for Pax7 in the absence of an established expression
map at different embryonic timepoints and in the postnatal mouse brain Previous

Pax? expression patterns have been described at the E13.5 timepoint and in adult
brain (Stoykova and Gruss, -1994) but the unavailability of a map at other crucial
timepoints during brain development hampered accurate expression description of

Pax7. The maps at E12.5, 15.5, 18.5, PO, PS and P21 that were generated in this
project allow the Pax7 expression pattern to be followed during brain development
and the early postnatal brain. Generally, the Pax7 positive regions stayed the same
throughout brain development although with varying densities of Pax7 expressing
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cells and/or varying intensities of Pax? at the different timepoints mentioned. The
mapping at the P21 timepoint revealed the adolescent brain to be comparable to that
of the adult brain both in terms of Pax? expression pattern and anatomical features.

5.5 APPLICATION OF GENETICALLY MANIPULATED
REPORTER MICE FOR SCL EXPRESSION
In the past monoclonal as well as polyclonal antiserum against Sci have been raised in
the group of Prof. Begley. Unfortunately, the use of these antisera proved limited in
immunohistochemistry. Only Smith et al, 2002 has reported successful
immunodetection of Sci in the embryonic spinal cord. It is thought that expression of
different Sci isoforms in different tissue or brain regions may not recognise or be
accessible to the antisera, explaining the failure of these antibodies in
immunohistochemistry. To alleviate this problem of Sci detection in brain sections,
van Eekelen et a!. ('03) have previously used the Scl LacZ knockin reporter mouse.
Newly generated transgenic mice expressing CreER(T) under the 0.9E3 neural
enhancer of Scl crossed to R26R reporter mice can also be used and this has been
described in detail in the introduction of this thesis. Unexpectedly, the 0.9E3
CreER(T) x R26RweYfp model presented some difficulties in this study. At some

embryonic timepoints the eY.fP signal did not reach the required detection threshold to
be able to confirm cowlocalisation with Pax? fluorescent staining using confocal
microscopy. This may be because the time allowed for eYfp production after the
tamoxifen injections was not long enough to generate sufficient eYfp protein to
autofluoresce a strong enough signal. Alternatively, some interference while crossing
the placenta may have reduced the amounts of available tamoxifen to the embryo to
reduce the gene recombination of the R26R locus to express eYfp. Further, as the
eYfp autofluoresces and no antibody to eYfp is avajlable, it is not possible to amplify
the signal as can be done when an immunofluorescent detection method is applied.

In summary, I have conducted a comparative expression analysis of two neurogenic
factors from different transcription factor families, of which expression of both is
sustained after birth in overlapping brain regions. These factors co-localise in the
same neurons of the superior colliculus but only after maturation of the brain. During
the process of brain development these two factors could have similar functions in
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neural differentiation but in segregated cascades of gene regulatory events for
different postmitotic neural progenitor populations.

5.6 FUTURE RESEARCH
Proposed short-term experimental research,
-To add complexity to this study, mapping the coronal sections of the mouse brain at
each timepoint wia allow a thorough three-dimensional analysis of the co-expression
patterns of Pax7 and Sci.
- To differentiate the layers of the superior colliculus particularly at those ages where
no specific map is available, gold myelin and acetyl cholinesterase stainings could be
carried out in adjacent sections. This is ideal to delineate the layers of the superior
colliculus and will allow better interpretation of the results on a cellular expression
basis.
- To ascertain whether the high expression of Pax7 in the dorsal superior colliculus at
PO and P5 is from migrating cells into the superior colliculus, which enhance the total
number of Pax7 expressing cells or an increased or newly induced expression within
existing cells of the dorsal layers, cell counting could be performed at El8.5 and PO.
Conversely, cell counting could determine whether the decreased density of staining
in the adult brain resulted from a downregulation of Pax 7 or an expansion of the
superior colliculus. This could be achieved by co-staining with Nissl and expression
of Pax7+ cells as a percentage of total cell counts.
- To determine overlapping and abutting expression patterns of Pax7 and other
described neurogenic factors contributing to the patterning of the embryonic brain to
study their involvement in the developmental cascades at the mid/forebrain and
mid/hindbrain boundaries. Co-staining experiments based on the use of different
antibodies against these factors involved at the boundary regions during embryonic
neurogenesis could be performed.

Proposed longer term experimental research,
To identify and quantify alterations of the expression patterns of Sci and Pax7
in the adult brain, lesion studies could be investigated. The studies based on the
destruction or deafferentation of specific brain regions may well verify whether Pa'C7
plays a role in the repair and maintenance of the midbrain after lesioning the retina-
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tectal connection thereby causing injury in need of a repair or regeneration process in
the superior collicuius itself.
To determine if different Sci isoforms exist within the brain, biochemical
analysis using Western blots could be perfonned.
Finally, to investigate whether Sci and Pax7 associate with each other or with
other factors in the same multiprotein complexes regulating gene expression
irnmunoprecipitation experiments could be conducted. To study whether Pax7 and

Sci regulate downstream genes or each other's expression can be addressed by
microarray analysis of cells in which both Pax7 and Sci are expressed.
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